学术周报 · IF≥10
骨科领域文献阅读汇编
2026年第41周 (2026-10-08) | PubMed (NLM) · DeepSeek 中英双语
数据来源: PubMed E-utilities · 影响因子筛选≥10 · 完整摘要不截断
数据来源: PubMed E-utilities · 影响因子筛选≥10 · 完整摘要不截断
★本周 Top 10 高影响力文献
Ŧ期刊分布统计
| 期刊 | 篇数 | IF |
|---|---|---|
| Bioactive materials | 8 | IF 23.6 |
| Biomaterials | 5 | IF 13.6 |
| Ageing research reviews | 4 | IF 15.5 |
| MedComm | 3 | IF 14.1 |
| British journal of anaesthesia | 3 | IF 10.3 |
| Journal of advanced research | 3 | IF 17.1 |
| Cytokine & growth factor reviews | 2 | IF 13.4 |
| Drugs | 2 | IF 14.7 |
| Pharmacological research | 2 | IF 12.2 |
| Carbohydrate polymers | 2 | IF 13.2 |
1骨质疏松/骨代谢 (16篇)
临床研究 (6篇)
Advancements occurred in the last century have gradually extended human lifespan. However, increased lifespan does not necessarily coincide with an equivalent extension of healthy life expectancy. The increasing gap of years between healthy and unhealthy life challenges individual aspirations for a meaningful longevity and strains the sustainability of health and social care systems. Aging remains the main risk factor for diseases, and comorbidity does not fully account for the disparities between healthy and unhealthy life expectancy. Moreover, disease-modifying and healthcare interventions reducing mortality not necessarily restore individual vitality, neither preserve functional independence. Accordingly, chronological age or metrics for single or multiple non-communicable diseases (NCDs) cannot appropriately capture the individual quality of life. The geriatric and gerontological science advanced the frailty syndrome at the crossroad between healthy and unhealthy trajectories of aging. Frail older adults carry a complex combination of features related to physiological aging, minor and major multi-systemic alterations, that start as compensatory mechanisms and flow into NCDs pathophysiological attributes. Orthogeriatric patients are paradigmatic examples of frail older adults. As acute stress, hip fracture challenges individual resilience leaving the subjects on the edge between homeostatic balance or derangement, short-term functional recovery or long-term dependency, and ultimately premature death. Upon hospital admission, the comprehensive geriatric assessment (CGA) is pivotal to detect and manage frailty and consequences, to drive preventive and curative interventions in the short and long-term period, including secondary prevention of falls and fragility fractures. Starting from the first episode, falls and fragility fractures should be timely assessed using CGA as possible multifaceted features of frailty. Timely interventions removing modifiable risk factors are recommended to counteract the frailty vicious cycle, including falls and fragility fractures, causing unhealthy life expectancy. The Fracture Liaison Service (FLS) is a coordinated care model designed to bridge the care gap of people facing fragility fractures in a time-dependent manner. Building on professionals' knowledge and competencies for caring older adults, FLS may be an avenue to detect frailty and place actions to reinforce individual intrinsic capacity from the acute care setting to home, and from hip fracture patients to forward.
中文摘要:上世纪取得的进步逐渐延长了人类寿命。然而,寿命延长并不必然伴随健康预期寿命的同等延长。健康生活年数与不健康生活年数之间不断扩大的差距,挑战了个体对有意义长寿的期望,并给健康与社会照护体系的可持续性带来压力。衰老仍是疾病的主要危险因素,而共病并不能完全解释健康预期寿命与不健康预期寿命之间的差异。此外,降低死亡率的疾病修饰干预和医疗干预未必能恢复个体活力,也未必能维持功能独立。因此,实际年龄或单一或多种非传染性疾病(NCDs)指标不能恰当反映个体生活质量。老年医学与老年学科学提出了衰弱综合征,其位于健康与不健康衰老轨迹的交叉点。衰弱老年人具有与生理性衰老、轻度和重度多系统改变相关的复杂特征组合,这些改变起初作为代偿机制出现,并发展为NCDs的病理生理特征。骨科老年患者是衰弱老年人的典型例子。作为一种急性应激,髋部骨折挑战个体韧性,使患者处于稳态平衡或失调、短期功能恢复或长期依赖,乃至最终过早死亡之间的边缘。入院时,老年综合评估(CGA)对于识别和管理衰弱及其后果至关重要,有助于指导短期和长期预防性和治疗性干预,包括跌倒和脆性骨折的二级预防。从首次事件开始,就应及时使用CGA评估跌倒和脆性骨折,将其视为衰弱可能的多方面表现。推荐及时干预以去除可改变的危险因素,从而对抗导致不健康预期寿命的衰弱恶性循环,包括跌倒和脆性骨折。骨折联络服务(FLS)是一种协调照护模式,旨在以时间依赖的方式弥合脆性骨折患者所面临的照护缺口。基于专业人员照护老年人的知识与能力,FLS可能是一条途径,用以识别衰弱并采取行动,从急性照护环境到家庭,并从髋部骨折患者继续向前推进,强化个体内在能力。
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly used for the treatment of type 2 diabetes and obesity, but their effects on musculoskeletal health remain completely misunderstood. This systematic review/meta-analysis aims to synthesise clinical data on the effects of GLP-1 RAs on key relevant bone, muscle, and joint outcomes. MEDLINE, Cochrane Central Register of Controlled Trials (CENTRAL) (both via Ovid® platform) and Embase were searched from inception to March 2025 to identify relevant randomised controlled trials (RCTs) or real-world evidence (RWE) studies to be included. This bibliographic search was completed manually. A random-effect model meta-analysis was performed for any outcome reported in at least 2 studies. Subgroup analyses were performed on the type of GLP-1 RAs, type of comparator used and study design. Sensitivity analyses (i.e., leave-out sensitivity analyses and analyses restricted to the most adjusted effect estimate) were performed to test the robustness of the data. The strength of evidence was assessed using GRADE. This work has been performed in adherence with PRISMA statement. (PROSPERO Record ID: CRD420251024082). From 1148 potentially relevant references, 60 articles (46 RCTs, 13 RWE studies and 1 pharmacovigilance study, comprising 1,250,717 individuals) met our inclusion criteria. Different GLP-1 RAs were represented across the panel of studies, i.e., semaglutide, liraglutide, exenatide, dulaglutide, tirzepatide (dual agonist gastric inhibitory polypeptide [GIP]/GLP-1) and others. No effect on bone outcomes (i.e., bone mineral density [all sites] and fractures [all sites]) were observed when the meta-analytical models included the most adjusted effect size. Regarding muscle outcomes, a significant decrease of lean body mass/fat-free mass was consistently observed with GLP-1 RAs in the global model (k = 28, standardised mean difference [SMD] 0.52, 95% confidence interval [CI] -0.8; -0.23, I2 88%, p-value for heterogeneity <0.0001), which remained robust in all sensitivity analyses. Subgroup analyses showed that the effect was mainly driven by liraglutide and semaglutide, with a decrease in lean body mass/fat-free mass observed when GLP-1 RAs were compared with placebo. No publication bias was found. Regarding joint outcome, models revealed no significant change in The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain, physical function and stiffness. This meta-analysis is the first to investigate the effects of GLP-1 RAs on a large panel of musculoskeletal health outcomes. While no significant effects were observed on bone- or joint-related outcomes, GLP-1 RAs were associated with reductions in lean body mass/fat-free mass, although the certainty of evidence was low and these changes appeared largely related to weight loss. Whether these changes translate into clinically meaningful impairments in muscle function or physical performance remains uncertain. Further studies in this field, including those looking at muscle function, strength or performance and using multivariate models considering confounding are needed to better reinforce the models and final findings.
中文摘要:胰高血糖素样肽-1受体激动剂(GLP-1 RAs)越来越多用于治疗2型糖尿病和肥胖,但其对肌肉骨骼健康的影响仍完全未被充分理解。本系统综述/Meta分析旨在综合关于GLP-1 RAs对关键相关骨骼、肌肉和关节结局影响的临床数据。检索MEDLINE、Cochrane对照试验中心注册库(CENTRAL)(均通过Ovid®平台)和Embase,从建库至2025年3月,以识别相关随机对照试验(RCTs)或真实世界证据(RWE)研究并纳入。该文献检索通过手工完成。对至少2项研究报告的任何结局进行随机效应模型Meta分析。按GLP-1 RAs类型、所用对照类型和研究设计进行亚组分析。进行敏感性分析(即留一敏感性分析和限制于最调整效应估计的分析)以检验数据的稳健性。使用GRADE评估证据强度。本工作遵循PRISMA声明进行。(PROSPERO注册号:CRD420251024082)。从1148篇可能相关的参考文献中,60篇文章(46项RCT、13项RWE研究和1项药物警戒研究,共包含1,250,717名个体)符合纳入标准。研究集合中涵盖了不同的GLP-1 RAs,即司美格鲁肽、利拉鲁肽、艾塞那肽、度拉糖肽、替尔泊肽(双重激动剂胃抑制多肽[GIP]/GLP-1)及其他。当Meta分析模型纳入最调整效应量时,未观察到对骨骼结局(即骨密度[所有部位]和骨折[所有部位])的影响。关于肌肉结局,在全球模型中一致观察到GLP-1 RAs导致瘦体重/去脂体重显著下降(k=28,标准化均数差[SMD] 0.52,95%置信区间[CI] -0.8;-0.23,I2 88%,异质性p值<0.0001),且在所有敏感性分析中保持稳健。亚组分析显示,该效应主要由利拉鲁肽和司美格鲁肽驱动,当GLP-1 RAs与安慰剂比较时观察到瘦体重/去脂体重下降。未发现发表偏倚。关于关节结局,模型显示西安大略和麦克马斯特大学骨关节炎指数(WOMAC)疼痛、身体功能和僵硬无显著变化。本Meta分析是首个研究GLP-1 RAs对一大组肌肉骨骼健康结局影响的研究。虽然未观察到对骨骼或关节相关结局的显著影响,但GLP-1 RAs与瘦体重/去脂体重减少相关,尽管证据确定性低,且这些变化似乎在很大程度上与体重减轻有关。这些变化是否转化为肌肉功能或身体表现方面具有临床意义的损害仍不确定。该领域需要进一步研究,包括关注肌肉功能、力量或表现并使用考虑混杂因素的多变量模型的研究,以更好地强化模型和最终发现。
To gain insight into higher fracture risk in individuals with type 2 diabetes, we determined the association of type 2 diabetes glycemic status and severity with longitudinal changes in peripheral bone density and microarchitecture. We conducted a longitudinal study of 769 participants from the Framingham Study who underwent high-resolution, peripheral, quantitative computed tomography (HR-pQCT) at the tibia and radius in 2012-2016 and 2021-2023 (mean 8-year follow-up). Linear regression models estimated mean 8-year percent changes in bone measures across indicators of diabetes severity, adjusting for age, sex, weight, and height. The mean age was 67 ± 7 years, and 59% of participants were women. More than half (57%) were normoglycemic (fasting plasma glucose [FPG] <100 mg/dL, not on any treatment), 31% had prediabetes (100 ≤ FPG ≤125 mg/dL), and 12% had type 2 diabetes (FPG >125 mg/dL or on treatment). Adjusted mean percent changes in HR-pQCT bone measures were similar across diabetes severity, including glycemic status, use of diabetes medications, duration of diabetes, and HbA1c. For example, cortical volumetric bone mineral density at the radius changed by -1.50% (95% CI -2.43, -0.56) in type 2 diabetes and -1.96% (-2.53, -1.39) in prediabetes, compared with -2.42% (-2.86, -1.97) in normoglycemia (reference group; all P > 0.05). The magnitude of peripheral bone loss over 8 years did not differ between individuals with type 2 diabetes and those with normoglycemia, suggesting that bone deterioration alone does not explain the higher fracture risk in older adults with type 2 diabetes. Future studies should address other contributors to skeletal fragility.
中文摘要:为了深入理解2型糖尿病患者骨折风险升高的原因,我们确定了2型糖尿病血糖状态及严重程度与外周骨密度和微结构纵向变化之间的关联。我们对Framingham研究中的769名参与者进行了纵向研究,这些参与者在2012—2016年和2021—2023年接受了胫骨和桡骨的高分辨率外周定量计算机断层扫描(HR-pQCT)(平均随访8年)。采用线性回归模型估计在糖尿病严重程度各项指标下骨测量指标8年平均百分比变化,并校正年龄、性别、体重和身高。平均年龄为67±7岁,59%的参与者为女性。超过一半(57%)血糖正常(空腹血糖[FPG]<100 mg/dL,未接受任何治疗),31%为糖尿病前期(100≤FPG≤125 mg/dL),12%患有2型糖尿病(FPG>125 mg/dL或正在接受治疗)。在校正后,HR-pQCT骨测量指标的平均百分比变化在糖尿病严重程度各指标间相似,包括血糖状态、糖尿病药物使用、糖尿病病程和HbA1c。例如,2型糖尿病患者的桡骨皮质体积骨密度变化为-1.50%(95% CI -2.43,-0.56),糖尿病前期为-1.96%(-2.53,-1.39),而血糖正常组为-2.42%(-2.86,-1.97)(参照组;所有P>0.05)。2型糖尿病患者与血糖正常者8年间外周骨丢失幅度没有差异,提示单纯的骨退化并不能解释老年2型糖尿病患者更高的骨折风险。未来研究应探讨导致骨骼脆性的其他因素。
Puberty is a critical window for bone mass acquisition, determining lifelong fracture risk. Gonadotropin-releasing hormone agonist (GnRHa)-based pubertal suppression followed by gender-affirming hormone therapy (GAHT) is increasingly used in transgender and gender-diverse (TGD) adolescents, raising concerns about peak bone mass. To quantify changes in bone mineral density (BMD), bone mineral apparent density (BMAD), and z scores in TGD adolescents undergoing GnRHa with or without GAHT, and to identify predictors of skeletal outcomes. PubMed, Scopus, Web of Science, and Cochrane Library, from inception through September 2025. Longitudinal cohorts assessing BMD, BMAD, or z scores at the lumbar spine, total hip, or femoral neck in TGD adolescents treated with GnRHa with or without GAHT. Ten studies met the inclusion criteria. Data were extracted in duplicate; study quality was assessed using the Newcastle-Ottawa Scale. Random-effects models pooled mean changes across baseline (time 0 [T0]), after GnRHa (T1), and after GAHT (T2), stratified by skeletal site and sex assigned at birth. Metaregressions examined body mass index, age, Tanner stage, and treatment duration. Dual-energy x-ray absorptiometry-derived BMD, BMAD, and z scores. Ten cohorts comprising 751 adolescents (427 assigned female at birth [AFAB]; 324 assigned male at birth [AMAB]) were included. Lumbar spine z scores declined during GnRHa (AFAB: z-score change, -0.97 [95% CI, -1.09 to -0.85]; AMAB: z-score change, -0.73 [95% CI, -0.93 to -0.53]) despite stable BMD. z Scores used sex-assigned-at-birth normative references. After GAHT, BMD increased (AFAB: BMD mean difference, 0.09 g/cm2 [95% CI, 0.07-0.10 g/cm2]; AMAB: BMD mean difference, 0.13 g/cm2 [95% CI, 0.10-0.16 g/cm2]), with partial z-score recovery; values remained below baseline at T2 (AFAB: z-score change, -0.51 [95% CI, -0.69 to -0.34]; AMAB: z-score change, -0.52 [95% CI, -0.82 to -0.21]) but were not consistently statistically different across skeletal sites. Recovery at the total hip and femoral neck was smaller and more heterogeneous. Higher body mass index, shorter GnRHa duration, and longer GAHT exposure were associated with more favorable outcomes. This systematic review and meta-analysis found that pubertal suppression followed by GAHT was associated with transient z-score reductions and subsequent BMD increases. At T2, z scores remained numerically below baseline but were not consistently statistically different, suggesting an uncertain rather than demonstrated persistent deficit. Timely GAHT initiation is recommended.
中文摘要:青春期是骨量积累的关键窗口,决定终生骨折风险。使用促性腺激素释放激素激动剂(GnRHa)进行青春期抑制,随后进行性别肯定激素治疗(GAHT),在跨性别和性别多元(TGD)青少年中应用日益增多,引发了对峰值骨量的担忧。旨在量化接受GnRHa(伴或不伴GAHT)的TGD青少年的骨密度(BMD)、骨表观密度(BMAD)和z评分的变化,并确定骨骼结局的预测因素。检索PubMed、Scopus、Web of Science和Cochrane Library,从建库至2025年9月。纳入评估接受GnRHa(伴或不伴GAHT)治疗的TGD青少年腰椎、全髋或股骨颈BMD、BMAD或z评分的纵向队列。十项研究符合纳入标准。数据由两人独立提取;使用纽卡斯尔-渥太华量表评估研究质量。采用随机效应模型汇总基线(时间0 [T0])、GnRHa后(T1)和GAHT后(T2)的平均变化,并按骨骼部位和出生时指定性别分层。Meta回归分析检查了体重指数、年龄、Tanner分期和治疗持续时间。双能X线吸收法得出的BMD、BMAD和z评分。共纳入10个队列,包括751名青少年(427名出生时指定女性[AFAB];324名出生时指定男性[AMAB])。尽管BMD稳定,GnRHa期间腰椎z评分下降(AFAB:z评分变化,-0.97 [95% CI,-1.09至-0.85];AMAB:z评分变化,-0.73 [95% CI,-0.93至-0.53])。z评分使用出生时指定性别的规范参考值。GAHT后,BMD增加(AFAB:BMD平均差,0.09 g/cm2 [95% CI,0.07-0.10 g/cm2];AMAB:BMD平均差,0.13 g/cm2 [95% CI,0.10-0.16 g/cm2]),z评分部分恢复;T2时数值仍低于基线(AFAB:z评分变化,-0.51 [95% CI,-0.69至-0.34];AMAB:z评分变化,-0.52 [95% CI,-0.82至-0.21]),但在各骨骼部位并不一致具有统计学差异。全髋和股骨颈的恢复较小且异质性更大。较高的体重指数、较短的GnRHa持续时间和较长的GAHT暴露与更有利的结局相关。这项系统评价和Meta分析发现,青春期抑制后接受GAHT与短暂的z评分降低和随后的BMD增加相关。在T2时,z评分在数值上仍低于基线,但并不一致具有统计学差异,表明存在不确定而非已证实的持续缺陷。建议及时启动GAHT。
To quantify the excess risk of any fractures, major osteoporotic fractures (MOF), and hip fractures in type 1 diabetes (T1D) by age, stages of diabetic kidney disease (DKD), and sex and to evaluate risk factors for fractures. The study included 5,035 individuals from the Finnish Diabetic Nephropathy Study (FinnDiane) and 12,286 control individuals without diabetes. We assessed the standardized incidence ratios (SIRs) for fractures in individuals with T1D compared with control individuals. Cox regression analyses were conducted in individuals with T1D to identify potential factors associated with fractures. SIR for any fracture was 2.15 (95% CI 2.06-2.25), 2.60 (2.41-2.79) for MOF, and 5.24 (4.55-6.02) for hip fracture. SIR of hip fracture was the highest in those aged 40-49 years, 8.13 (5.75-11.2). All age-groups after 10-19 years had excess fracture risk. The SIR of any fracture increased with the DKD stages; 2.54 (2.36-2.72) in individuals without albuminuria, 3.47 (3.02-3.98) in those with moderate albuminuria, 3.73 (3.27-4.25) in those with severe albuminuria, and 5.08 (4.16-6.16) in those with kidney failure. SIRs for MOF were 2.62 (2.34-2.93) in those without albuminuria, 3.84 (3.10-4.71) in those with moderate albuminuria, 4.53 (3.72-5.48) in those with severe albuminuria, and 5.85 (4.38-7.68) in those with kidney failure. Hypoglycemic coma episodes (hazard ratio 1.04 [1.01-1.07]) and HbA1c (1.11 [1.06-1.15]) were associated with risk of any fracture, and episodes of diabetic ketoacidosis were associated with risk of MOF (1.18 [1.11-1.25]) in T1D. Findings suggest that fracture risk assessment may need to be considered earlier than currently recommended, especially among individuals with DKD.
中文摘要:量化1型糖尿病(T1D)患者中按年龄、糖尿病肾病(DKD)分期和性别分层的任何骨折、主要骨质疏松性骨折(MOF)和髋部骨折的超额风险,并评估骨折的危险因素。该研究纳入芬兰糖尿病肾病研究(FinnDiane)的5,035名个体和12,286名无糖尿病对照个体。我们评估了T1D个体与对照个体相比骨折的标准化发病比(SIR)。在T1D个体中进行Cox回归分析,以识别与骨折相关的潜在因素。任何骨折的SIR为2.15(95% CI 2.06-2.25),MOF为2.60(2.41-2.79),髋部骨折为5.24(4.55-6.02)。髋部骨折SIR在40-49岁年龄组最高,为8.13(5.75-11.2)。10-19岁之后的各年龄组均有骨折超额风险。任何骨折的SIR随DKD分期增加而升高;无白蛋白尿个体为2.54(2.36-2.72),中度白蛋白尿者为3.47(3.02-3.98),重度白蛋白尿者为3.73(3.27-4.25),肾衰竭者为5.08(4.16-6.16)。MOF的SIR在无白蛋白尿者为2.62(2.34-2.93),中度白蛋白尿者为3.84(3.10-4.71),重度白蛋白尿者为4.53(3.72-5.48),肾衰竭者为5.85(4.38-7.68)。低血糖昏迷发作(风险比1.04 [1.01-1.07])和HbA1c(1.11 [1.06-1.15])与任何骨折风险相关,糖尿病酮症酸中毒发作与T1D中MOF风险相关(1.18 [1.11-1.25])。研究结果提示,骨折风险评估可能需要比目前推荐更早考虑,尤其对于DKD个体。
Lumbar CT and MRI scans are helpful for osteoporosis (OP) screening. Deep learning enhances the efficiency and accuracy of musculoskeletal quantification for OP screening. To develop a deep learning-based model (UNet3D) for musculoskeletal quantification from lumbar CT and MRI in OP patients, and to explore musculoskeletal relationship. Retrospectively analyzing OP patients' lumbar CT, MRI and DXA scans between January 2018 and August 2025 from two center, and UNet3D was developed based on U-Net to simultaneously segment L1-S1 vertebrae on CT and paraspinal muscles/intermuscular spaces on MRI. Performance was compared against U-Net, U2-Net, Mask-RCNN using pixel accuracy (PA), mean pixel accuracy (mPA), mean intersection over union (mIoU). Following automated HU values calculation within cancellous bone volume of interests (VOIs), we correlated L1-L4 HU values with T-scores and analyzed their relationship with muscle/space volumes across L1-S1, computing corresponding weighting coefficients. The study analyzed 410 OP patients (65 ± 10 years; 240 women) with 76,700 axial CT and 6210 axial T2 slices, including training (266), validation (76), internal test (38) and external test (30) sets. On the internal test set, UNet3D's accuracy in CT (PA/mPA/mIoU, 0.984/0.849/0.760) and MRI (PA/mPA/mIoU, 0.973/0.849/0.724), outperformed U-Net/U2-Net/Mask R-CNN. On the external test set, UNet3D attained PA, mPA, and mIoU values of 0.971, 0.852, 0.741 in CT, and of 0.969, 0.834, 0.713 in MRI. HU values varied across vertebral VOIs, ranging from 80.33 HU (L2) to 195.14 HU (S1), and correlations existed between L1-L4 HU values and T-scores (r ≥ 0.85, P < 0.05). Volumetric measurements across L1-S1 identified the psoas major as the largest muscle (173,317.68 mm3) and the quadratus lumborum as the smallest (65,167.78 mm3); among spaces, the psoas-vertebral was largest (124,301.86 mm3) and the quadratus lumborum-iliocostalis was smallest (29,676.63 mm3). Vertebral HU values correlated positively with muscle volumes (ω > 0) and negatively with space volumes and fatty infiltration (ω < 0). UNet3D outperformed U-Net/U2-Net/Mask R-CNN on CT/MRI segmentation, enabling accurate musculoskeletal volume quantification in OP patients. Musculoskeletal correlations differed across spinal segments.
中文摘要:腰椎CT和MRI扫描有助于骨质疏松症(OP)筛查。深度学习提高了用于OP筛查的肌肉骨骼量化的效率和准确性。开发基于深度学习的模型(UNet3D),用于从OP患者的腰椎CT和MRI中进行肌肉骨骼量化,并探讨肌肉骨骼关系。回顾性分析2018年1月至2025年8月来自两个中心的OP患者腰椎CT、MRI和DXA扫描,并基于U-Net开发UNet3D,以在CT上同时分割L1-S1椎体,在MRI上分割椎旁肌/肌间隙。使用像素准确率(PA)、平均像素准确率(mPA)、平均交并比(mIoU)将其性能与U-Net、U2-Net、Mask-RCNN进行比较。在自动计算松质骨感兴趣体积(VOIs)内的HU值后,我们将L1-L4 HU值与T值进行相关性分析,并分析其与L1-S1肌肉/间隙体积的关系,计算相应的权重系数。该研究分析了410例OP患者(65±10岁;240例女性),包含76,700层轴位CT和6210层轴位T2切片,包括训练集(266)、验证集(76)、内部测试集(38)和外部测试集(30)。在内部测试集上,UNet3D在CT(PA/mPA/mIoU,0.984/0.849/0.760)和MRI(PA/mPA/mIoU,0.973/0.849/0.724)中的准确性优于U-Net/U2-Net/Mask R-CNN。在外部测试集上,UNet3D在CT中达到PA、mPA和mIoU值分别为0.971、0.852、0.741,在MRI中分别为0.969、0.834、0.713。HU值在不同椎体VOIs间存在差异,范围从80.33 HU(L2)到195.14 HU(S1),且L1-L4 HU值与T值之间存在相关性(r≥0.85,P<0.05)。L1-S1的体积测量确定腰大肌为最大肌肉(173,317.68 mm3),腰方肌为最小肌肉(65,167.78 mm3);在间隙中,腰大肌-椎体间隙最大(124,301.86 mm3),腰方肌-髂肋肌间隙最小(29,676.63 mm3)。椎体HU值与肌肉体积呈正相关(ω>0),与间隙体积和脂肪浸润呈负相关(ω<0)。UNet3D在CT/MRI分割上优于U-Net/U2-Net/Mask R-CNN,能够对OP患者进行准确的肌肉骨骼体积量化。肌肉骨骼相关性在不同脊柱节段间存在差异。
基础研究 (10篇)
Iron is the most abundant trace element, driving both the commonest deficiency and ferroptosis. This review takes iron as the central theme and extends to copper, zinc, and calcium, spanning physiological functions, pathological mechanisms, risk factors, diagnostics, and therapeutics. We classify these ions into redox-active (iron, copper), which engage in catalytic electron transfer, and redox-inert (zinc, calcium), which serve structural and signaling roles without redox cycling. Iron deficiency remains the global leading micronutrient deficit, whereas iron overload triggers ferroptosis-mediated organ damage. Copper deficiency manifests as hematological and neurological syndromes, while copper excess induces cuproptosis. Zinc deficiency impairs growth and immunity, yet chronic zinc toxicity primarily causes secondary copper deficiency. Calcium dysregulation underpins hypoparathyroidism, osteoporosis, cardiovascular diseases, and crystal deposition disorders. Diagnosis integrates clinical assessment, biochemical profiling, imaging, and genetic analysis; risk factors encompass dietary insufficiency, environmental exposure, genetic variants, and demographic variables. Given the narrow therapeutic window between deficiency and toxicity, vigilant monitoring is mandatory. Treatment strategies are metal-specific and include chelation, hormone replacement, source removal, and channel modulation. Future directions emphasize validated biomarkers, tissue-targeted delivery, and metallo-genomics to enable precision medicine, with iron metabolism as a pivotal entry point for understanding and managing systemic metal homeostasis.
中文摘要:铁是最丰富的微量元素,既驱动最常见的缺乏症,也驱动铁死亡。本文以铁为核心主题,并扩展至铜、锌和钙,涵盖生理功能、病理机制、危险因素、诊断和治疗。我们将这些离子分为氧化还原活性离子(铁、铜),它们参与催化性电子转移,以及氧化还原惰性离子(锌、钙),它们发挥结构和信号传导作用而不进行氧化还原循环。铁缺乏仍是全球最主要的微量营养素缺乏,而铁过载则触发铁死亡介导的器官损伤。铜缺乏表现为血液学和神经系统综合征,而铜过量诱导铜死亡。锌缺乏损害生长和免疫,但慢性锌毒性主要引起继发性铜缺乏。钙调节异常是甲状旁腺功能减退、骨质疏松、心血管疾病和晶体沉积性疾病的基础。诊断整合临床评估、生化分析、影像学和遗传分析;危险因素包括膳食不足、环境暴露、遗传变异和人口学变量。鉴于缺乏与毒性之间的治疗窗狭窄,必须进行警惕性监测。治疗策略因金属而异,包括螯合、激素替代、去除来源和通道调节。未来方向强调经过验证的生物标志物、组织靶向递送和金属基因组学,以实现精准医学,其中铁代谢是理解和管理系统性金属稳态的关键切入点。
The balance between bone formation and bone marrow adipose tissue accumulation is essential for skeletal integrity, and disruption of this balance contributes to skeletal degeneration, osteoporosis, and metabolic bone loss. However, the molecular mechanisms controlling this balance across skeletal homeostasis and disease remain unclear. Here, transcriptomic analysis of human osteoporotic bone samples revealed significant downregulation of Ift20 and Wwtr1 in osteoblast-lineage cells. Using osteoblast-specific knockout models, we found that loss of both Ift20 and Wwtr1 in the osteoblast lineage caused severe bone loss and excessive bone marrow adipose tissue accumulation, which was further aggravated under ovariectomy and high-fat diet conditions. Mechanistically, Ift20 localized to primary cilia and interacted with transforming growth factor-β receptor II (TβRII), protecting it from c-Cbl-mediated ubiquitination and degradation to sustain TGF-β signaling. Meanwhile, Wwtr1 directly bound the TβRII promoter to promote its transcription. Loss of Ift20 and Wwtr1 converged on TβRII suppression, impairing osteoblast differentiation while enhancing adipogenesis and osteoclastogenesis. These findings reveal a previously unrecognized cilia-transcription-TGF-β regulatory mechanism that governs osteoblast-adipocyte fate decisions and skeletal remodeling. The Ift20-Wwtr1-TβRII axis represents a critical safeguard of bone mass and marrow fat balance and may provide a therapeutic target for osteoporosis and metabolic bone diseases.
中文摘要:骨形成与骨髓脂肪组织积累之间的平衡对骨骼完整性至关重要,这种平衡的破坏会导致骨骼退变、骨质疏松和代谢性骨丢失。然而,在骨骼稳态和疾病中控制这一平衡的分子机制仍不清楚。在此,对人骨质疏松骨样本的转录组分析显示,成骨细胞谱系细胞中Ift20和Wwtr1显著下调。利用成骨细胞特异性敲除模型,我们发现成骨细胞谱系中Ift20和Wwtr1的同时缺失导致严重骨丢失和骨髓脂肪组织过度积累,并且在卵巢切除和高脂饮食条件下进一步加重。机制上,Ift20定位于初级纤毛,并与转化生长因子-β受体II(TβRII)相互作用,保护其免受c-Cbl介导的泛素化和降解,从而维持TGF-β信号。同时,Wwtr1直接结合TβRII启动子以促进其转录。Ift20和Wwtr1的缺失共同导致TβRII抑制,损害成骨细胞分化,同时增强脂肪生成和破骨细胞生成。这些发现揭示了一种先前未被认识的纤毛-转录-TGF-β调控机制,该机制调控成骨细胞-脂肪细胞命运决定和骨骼重塑。Ift20-Wwtr1-TβRII轴是骨量和骨髓脂肪平衡的关键保障,并可能为骨质疏松和代谢性骨病提供治疗靶点。
Aging of the skeleton is a hallmark of organismal decline and underlies prevalent age-related disorders such as osteoporosis and osteoarthritis. Bone marrow-derived mesenchymal stem cells (BMSCs), the primary source of osteoblasts, undergo profound functional deterioration during senescence, leading to an imbalance between bone formation and resorption. This review systematically summarizes the key features of BMSC senescence, including impaired proliferation and differentiation, epigenetic dysregulation, and the acquisition of a pro-inflammatory senescence-associated secretory phenotype (SASP). We highlight recent advances in understanding how epigenetic mechanisms (DNA methylation, histone modifications, RNA methylation, and non-coding RNAs) orchestrate BMSC aging. In addition, we discuss the intricate crosstalk between senescent BMSCs and the bone microenvironment, emphasizing their contribution to age-related bone diseases. Finally, we propose future research directions, including the integration of multi‑omics, single-cell technologies, and targeted epigenetic interventions, as well as emerging therapeutic strategies such as senolytics, metabolic modulators, and extracellular vesicle-based approaches. A deeper understanding of BMSC aging will facilitate the development of novel treatments to preserve bone health and combat aging-related skeletal disorders.
中文摘要:骨骼衰老是机体衰退的标志,也是骨质疏松症和骨关节炎等常见年龄相关疾病的基础。骨髓来源间充质干细胞(BMSCs)是成骨细胞的主要来源,在衰老过程中发生深刻的功能退化,导致骨形成与骨吸收失衡。本综述系统总结了BMSC衰老的关键特征,包括增殖和分化受损、表观遗传失调以及获得促炎性衰老相关分泌表型(SASP)。我们重点介绍了在理解表观遗传机制(DNA甲基化、组蛋白修饰、RNA甲基化和非编码RNA)如何调控BMSC衰老方面的最新进展。此外,我们讨论了衰老BMSC与骨微环境之间复杂的相互作用,强调它们对年龄相关骨疾病的贡献。最后,我们提出了未来的研究方向,包括整合多组学、单细胞技术和靶向表观遗传干预,以及新兴治疗策略,如衰老细胞清除药物、代谢调节剂和基于细胞外囊泡的方法。对BMSC衰老的更深入理解将有助于开发新的治疗方法,以维护骨骼健康并对抗衰老相关的骨骼疾病。
Organophosphate esters (OPEs), used as both plasticizers and flame retardants, are increasingly recognized for their potential to disrupt cellular homeostasis and emerging evidence indicates their ability to induce metabolic stress in diverse biological systems. This study investigated the impact of Triphenyl Phosphate (TPhP) on human mesenchymal stem cell (hMSC) differentiation and cell stress. hMSCs were treated with DMSO (vehicle control), 10 µM rosiglitazone (a PPARγ agonist), or 25 µM TPhP for 14-21 days. Following treatment, cells were stained to assess nuclear integrity, lipid accumulation, and mineralization. Immunocytochemistry (ICC) for osteogenic and adipogenic markers was used to determine whether TPhP promotes adipogenesis under osteogenic conditions. TPhP exposure led to significant lipid accumulation without activation of adipogenic differentiation programs and markedly reduced mineralization. In particular, co-treatment with PPARγ inhibitors did not mitigate lipid accumulation or modulate the expression of adipogenic regulators. Gene expression analysis following TPhP exposures revealed upregulation of pathways involved in lipid biogenesis, triglyceride synthesis, phospholipid metabolism and endoplasmic reticulum (ER) stress, with minimal changes to classical adipogenic markers. These findings indicate that TPhP disrupts the metabolic balance between osteogenesis and lipid metabolism, with the potential to promote ectopic lipid deposition within the bone forming environment. This dysregulation is relevant for the development of metabolic disorders, including obesity, type 2 diabetes, and metabolic bone diseases, including osteoporosis.
中文摘要:有机磷酸酯(OPEs)同时用作增塑剂和阻燃剂,其破坏细胞稳态的潜力日益受到关注,新出现的证据表明其能够在多种生物系统中诱导代谢应激。本研究探讨了磷酸三苯酯(TPhP)对人间充质干细胞(hMSC)分化和细胞应激的影响。hMSCs分别用DMSO(溶剂对照)、10 µM 罗格列酮(PPARγ激动剂)或25 µM TPhP处理14-21天。处理后,对细胞进行染色以评估核完整性、脂质蓄积和矿化。采用针对成骨和成脂标志物的免疫细胞化学(ICC)来判断TPhP是否在成骨条件下促进成脂。TPhP暴露导致显著的脂质蓄积,但未激活成脂分化程序,并显著减少矿化。特别是,与PPARγ抑制剂共处理并未减轻脂质蓄积,也未调节成脂调控因子的表达。TPhP暴露后的基因表达分析显示,涉及脂质生成、甘油三酯合成、磷脂代谢和内质网(ER)应激的通路上调,而经典成脂标志物变化极小。这些发现表明,TPhP破坏了成骨与脂质代谢之间的代谢平衡,并可能促进骨形成环境中的异位脂质沉积。这种失调与代谢性疾病的发生相关,包括肥胖、2型糖尿病以及代谢性骨病,包括骨质疏松。
Aging causes osteoporosis, delayed fracture repair, and osteoarthritis, but mechanisms and therapies remain unclear. Transcriptomics of serum and bone from older patients showed marked MMP9 upregulation, highlighting systemic MMP9 neutralization as a potential immunotherapy. Here, we developed an in vivo circRNA-based antibody-engineering strategy that specifically targets macrophages, converting them into biofactories for anti-MMP9 antibodies. Central to this therapy is an apoptosis-mimicking lipid nanoparticle incorporating phosphatidylserine with an optimized formulation (aMMP9-LNP), which enhances macrophage-specific recognition and endocytosis. Leveraging inflammation-guided chemotaxis, this approach enables systemic, targeted MMP9 neutralization. In aged mice, systemic aMMP9-LNP reduced stem cell senescence, boosted osteogenesis, accelerated fracture repair, and mitigated cartilage degeneration. Mechanistically, MMP9 blockade dampened senescence-associated secretory phenotype, restored osteoblast-osteoclast balance, and lowered p21/MMP3. Biodistribution confirmed bone-targeted delivery with preserved tissue homeostasis, supporting translational potential. Collectively, our results identify MMP9 as a key effector and advance an in vivo mRNA immunotherapy for skeletal aging.
中文摘要:衰老可导致骨质疏松、骨折修复延迟和骨关节炎,但其机制和治疗仍不清楚。对老年患者血清和骨骼的转录组学分析显示MMP9显著上调,提示全身性MMP9中和可能是一种潜在的免疫治疗策略。在此,我们开发了一种基于体内circRNA的抗体工程策略,该策略特异性靶向巨噬细胞,将其转化为抗MMP9抗体的生物工厂。该疗法的核心是一种模拟凋亡的脂质纳米颗粒,其结合磷脂酰丝氨酸并采用优化配方(aMMP9-LNP),可增强巨噬细胞特异性识别和内吞。利用炎症引导的趋化作用,该方法实现了全身性、靶向的MMP9中和。在衰老小鼠中,全身给予aMMP9-LNP可减少干细胞衰老、促进成骨、加速骨折修复并减轻软骨退变。机制上,阻断MMP9抑制了衰老相关分泌表型,恢复了成骨细胞-破骨细胞平衡,并降低了p21/MMP3。生物分布证实其具有骨靶向递送并维持组织稳态,支持其转化潜力。总之,我们的结果确定MMP9是关键效应分子,并推进了一种用于骨骼衰老的体内mRNA免疫治疗。
Cell membrane-camouflaged nanoparticles have emerged as powerful tools for targeted drug delivery; however, current strategies typically utilize membranes from static cell states, overlooking the dynamic functional evolution that occurs during lineage commitment. Here, we established a stepwise osteogenic differentiation model for BMSCs and isolated cell membranes from distinct stages of this process to construct a series of cell membrane-camouflaged mesoporous silica nanoparticles (CM-MSNs). Proteomic profiling revealed stage-dependent remodeling of membrane protein composition, with early osteogenic (EO) stage membranes uniquely enriched in phosphatases and cadherins. Functional evaluations showed stage-dependent activity among CM-MSNs, and EO membrane-camouflaged nanoparticles (EO-MSNs) exhibited the strongest capacity to promote calcium deposition and enhance BMSC osteogenesis in vitro via the Wnt/β-catenin signaling pathway. In a rat model of osteoporosis, EO-MSN exhibited prolonged circulation time, precise bone-specific accumulation, and potent anti-osteoporotic efficacy. Collectively, our findings suggest that utilizing stage-specific cell membranes offers a novel strategy to remodel the osteoporotic microenvironment by modulating the osteoblast-adipocyte equilibrium.
中文摘要:细胞膜伪装纳米颗粒已成为靶向药物递送的有力工具;然而,当前策略通常使用处于静态细胞状态的细胞膜,忽视了谱系定向过程中发生的动态功能演化。在此,我们建立了BMSCs的逐步成骨分化模型,并从该过程的不同阶段分离细胞膜,以构建一系列细胞膜伪装介孔二氧化硅纳米颗粒(CM-MSNs)。蛋白质组学分析揭示了膜蛋白组成的阶段依赖性重塑,其中早期成骨(EO)阶段细胞膜独特地富集磷酸酶和钙黏蛋白。功能评估显示CM-MSNs具有阶段依赖性活性,且EO膜伪装纳米颗粒(EO-MSNs)在体外通过Wnt/β-catenin信号通路表现出最强的促进钙沉积和增强BMSC成骨的能力。在骨质疏松大鼠模型中,EO-MSN表现出延长的循环时间、精确的骨特异性蓄积以及强效的抗骨质疏松疗效。总之,我们的研究结果表明,利用阶段特异性细胞膜提供了一种通过调节成骨细胞-脂肪细胞平衡来重塑骨质疏松微环境的新策略。
Teriparatide is a representative anabolic agent for the treatment of osteoporosis; however, its therapeutic efficacy relies on intermittent exposure, necessitating frequent administration and thereby limiting long-term patient compliance. To address this limitation, we developed a programmable pulsatile delivery platform based on uniform core-shell microspheres fabricated via a W1/O/W2 double-emulsion process combined with premix membrane emulsification (PME). Through precise regulation of polymer phase separation, teriparatide is preferentially localized within the microsphere core. Core-shell microspheres constructed with PLLA shells of 7, 36, and 78 kDa exhibit well-defined pulsatile release profiles in vitro, each generating a major release event at approximately 7, 14, and 21 days, respectively, with about 40% of the loaded drug discharged during each pulse. In ovariectomized mice, a single administration of the combined microsphere combination formulation enhances bone formation, suppresses bone resorption, and markedly restores trabecular bone microarchitecture over a one-month treatment period, achieving therapeutic outcomes comparable to those of weekly teriparatide solution injections. Collectively, these findings demonstrate that PME-assisted phase separation core-shell microspheres enable synchronized and temporally programmable pulsatile delivery of teriparatide, offering a versatile platform for long-acting peptide therapeutics in osteoporosis management.
中文摘要:特立帕肽是治疗骨质疏松症的代表性骨合成代谢药物;然而,其治疗效果依赖于间歇性暴露,因此需要频繁给药,从而限制了患者的长期依从性。为解决这一局限,我们开发了一种基于均一核壳微球的可编程脉冲式递送平台,该微球通过W1/O/W2复乳法结合预混膜乳化(PME)制备。通过精确调控聚合物相分离,特立帕肽优先定位于微球核心。以7、36和78 kDa的PLLA壳层构建的核壳微球在体外表现出明确的脉冲释放曲线,分别在约7、14和21天产生一次主要释放事件,每次脉冲释放约40%的载药量。在去卵巢小鼠中,单次给予组合微球制剂可在为期一个月的治疗期内增强骨形成、抑制骨吸收,并显著恢复骨小梁微结构,其治疗效果与每周注射特立帕肽溶液相当。总之,这些发现表明,PME辅助相分离核壳微球能够实现特立帕肽的同步且时间可编程的脉冲式递送,为骨质疏松症管理中的长效肽类治疗提供了一个通用平台。
The global aging crisis presents significant challenges in treating age-related skeletal disorders, characterized by impaired bone regeneration due to senescent microenvironment dysfunction. While anti-senescence drugs have shown promising therapeutic potential, their clinical use is hindered by severe side effects and limited regenerative efficacy. Biomaterials-based anti-senescence strategies offer a promising alternative. This study is the first to demonstrate that silicate bioceramics possess not only osteogenic properties but also intrinsic anti-senescence capabilities, laying the foundation for the concept of "Silicate Anti-Senescence (SAS)". Using hardystonite (Ca2ZnSi2O7, ZnCS), one of the classic silicate-bioceramics, we reveal its biphasic biological function-delaying cellular senescence and promoting bone formation-through various formulations, including porous scaffolds, ionic extracts, and particle suspensions. In vitro, ZnCS effectively delays senescence of bone marrow mesenchymal stem cells (BMSCs) and enhances osteogenic differentiation. In vivo, ZnCS 3D scaffolds remodel the senescent microenvironment and accelerate osteoporotic bone regeneration, while oral administration of ZnCS particles exhibits significant anti-osteoporotic effects. Mechanistically, Zn2+ and SiO32- ions released from ZnCS exert synergistic effects that converge on the PI3K-AKT-SIRT1 signaling axis, thereby attenuating senescence-associated programs and reinforcing osteogenic gene networks. Notably, compared to classic anti-senescence drugs (dasatinib and quercetin), ZnCS shows superior performance compared to the control groups in both anti-senescence and osteogenesis. The study provides new insights into developing anti-senescence strategies for age-related skeletal diseases with silicate-based bioceramics.
中文摘要:全球老龄化危机给年龄相关骨骼疾病的治疗带来了重大挑战,其特征是衰老微环境功能障碍导致骨再生受损。尽管抗衰老药物已显示出有前景的治疗潜力,但其临床应用受到严重副作用和再生疗效有限的阻碍。基于生物材料的抗衰老策略提供了一种有前景的替代方案。本研究首次证明,硅酸盐生物陶瓷不仅具有成骨特性,还具有内在的抗衰老能力,为「硅酸盐抗衰老(SAS)」概念奠定了基础。使用锌黄长石(hardystonite,Ca2ZnSi2O7,ZnCS)这一经典硅酸盐生物陶瓷,我们通过多种制剂形式,包括多孔支架、离子提取物和颗粒悬浮液,揭示了其双相生物学功能——延缓细胞衰老和促进骨形成。在体外,ZnCS有效延缓骨髓间充质干细胞(BMSCs)的衰老并增强成骨分化。在体内,ZnCS 3D支架重塑衰老微环境并加速骨质疏松性骨再生,而口服ZnCS颗粒表现出显著的抗骨质疏松作用。机制上,ZnCS释放的Zn2+和SiO3^2-离子发挥协同作用,汇聚于PI3K-AKT-SIRT1信号轴,从而减弱衰老相关程序并强化成骨基因网络。值得注意的是,与经典抗衰老药物(达沙替尼和槲皮素)相比,ZnCS在抗衰老和成骨两方面均表现出优于对照组的性能。该研究为利用硅酸盐基生物陶瓷开发年龄相关骨骼疾病的抗衰老策略提供了新见解。
Osteoimmune-regulative metal-organic framework nanomedicine for effective osteoporosis therapeutics.
Osteoporosis is a global degenerative bone disorder in the elderly caused by the aging of bone and immune systems. Current therapeutics for osteoporosis focus on medical control over the osteoblast and osteoclast, resulting in complicated procedures and side effects. Regulation of osteoimmunity is of high significance for biocompatible and effective osteoporosis treatment. In the present work, we have designed a strontium phosphate (SP)-coated hollow zeolitic imidazolate framework-8 (hZIF) nanomedicine by chemical mineralization in which vitamin D3 (VD) has been further encapsulated. The formulated VD@SP-hZIF nanoparticles exhibit robust osteoimmune-regulative effects (anti-inflammatory, pro-osteogenesis, and calcium absorption promotion) in aged murine osteoporotic models respectively due to the constructed moieties of zinc ions, strontium phosphates and the loaded VD. The in-depth osteoporotic therapeutic mechanism of VD@SP-hZIF nanoparticles has also been explored. The present work highlights the construction of the metal-organic framework nanomedicines for effective regulation of osteoimmune microenvironment against osteoporosis, providing a highly applicable therapeutic paradigm towards pathologies with inflammatory disorders.
中文摘要:骨质疏松是一种全球性的老年退行性骨病,由骨骼和免疫系统衰老引起。目前的骨质疏松治疗主要集中于对成骨细胞和破骨细胞的医学调控,导致操作复杂和副作用。骨免疫调控对于实现生物相容且有效的骨质疏松治疗具有重要意义。在本研究中,我们通过化学矿化设计了一种磷酸锶(SP)包覆的中空沸石咪唑酯骨架-8(hZIF)纳米药物,并进一步包封了维生素D3(VD)。所制备的VD@SP-hZIF纳米颗粒在老年小鼠骨质疏松模型中表现出强健的骨免疫调控效应(抗炎、促骨形成和促进钙吸收),这归因于所构建的锌离子、磷酸锶和负载VD等组分。还深入探究了VD@SP-hZIF纳米颗粒的骨质疏松治疗机制。本研究突出了构建金属有机框架纳米药物以有效调控骨免疫微环境对抗骨质疏松,为炎症性疾病病理提供了一种高度适用的治疗范式。
Osteoporosis, a "silent killer" among the elderly, is marked by progressive bone loss and microstructural deterioration. Oligopeptides derived from black bean, particularly tetrapeptides, have shown notable osteogenic potential, yet their therapeutic roles in regulating bone metabolism and preventing osteoporosis remain unclear. This study explored the osteoanabolic effects of black bean-derived tetrapeptides and elucidated their underlying mechanisms. In vitro assays were conducted using MC3T3-E1 pre-osteoblasts derived from mouse calvaria to assess osteogenic differentiation upon tetrapeptide treatment. Six black bean tetrapeptides were evaluated, including KIGT, KGVG, KTGV, SIKL, KLGT, and SLKL. In vivo efficacy was evaluated in an ovariectomized mouse model of osteoporosis via intragastric administration. Based on molecular docking, the mechanisms were explored using Western blotting and immunofluorescence and validated through pathway inhibitor and siRNA knockdown experiments. All six tetrapeptides significantly stimulated the osteogenic differentiation of MC3T3-E1 pre-osteoblasts, particularly during early osteogenesis. Notably, the peptides all exhibited osteogenic effects at low doses (0.1 μM), although their optimal concentrations varied. Mechanistic studies revealed a shared anabolic pathway among the tetrapeptides, in which lysine residues may play a pivotal role in mediating their similar interactions with bone morphogenetic protein-2 (BMP-2), thereby activating the BMP-2/Smad signaling. Furthermore, this potent osteoanabolic efficacy was confirmed in osteoporotic mice, where a 10-week treatment with black bean oligopeptides (<1 kD), KIGT, and KGVG (100 mg/kg) markedly attenuated bone loss. Lysine-containing tetrapeptides derived from black bean exert direct osteoanabolic activity by targeting BMP-2/Smad signaling in osteoblasts. These findings support their potential as novel anabolic candidates against osteoporosis, paving the way for the development of oligopeptide-based therapies targeting bone health.
中文摘要:骨质疏松症是老年人中的「无声杀手」,以进行性骨丢失和微结构退化为特征。源自黑豆的寡肽,尤其是四肽,已显示出显著的成骨潜力,但其在调节骨代谢和预防骨质疏松中的治疗作用仍不清楚。本研究探讨了黑豆来源四肽的促骨形成作用,并阐明其潜在机制。采用源自小鼠颅骨的MC3T3-E1前成骨细胞进行体外实验,以评估四肽处理后的成骨分化。评估了六种黑豆四肽,包括KIGT、KGVG、KTGV、SIKL、KLGT和SLKL。通过灌胃给药在去卵巢小鼠骨质疏松模型中评估体内疗效。基于分子对接,使用Western blotting和免疫荧光探索机制,并通过通路抑制剂和siRNA敲低实验进行验证。所有六种四肽均显著刺激MC3T3-E1前成骨细胞的成骨分化,尤其是在早期成骨阶段。值得注意的是,这些肽在低剂量(0.1 μM)下均表现出成骨作用,尽管其最佳浓度各不相同。机制研究揭示这些四肽具有共同的合成代谢通路,其中赖氨酸残基可能在介导它们与骨形态发生蛋白-2(BMP-2)的相似相互作用中起关键作用,从而激活BMP-2/Smad信号通路。此外,这种强效的促骨形成作用在骨质疏松小鼠中得到证实,用黑豆寡肽(<1 kD)、KIGT和KGVG(100 mg/kg)治疗10周可显著减轻骨丢失。源自黑豆的含赖氨酸四肽通过靶向成骨细胞中的BMP-2/Smad信号通路发挥直接促骨形成活性。这些发现支持其作为抗骨质疏松新型合成代谢候选物的潜力,为开发针对骨健康的寡肽疗法铺平了道路。
2骨关节炎/软骨 (11篇)
临床研究 (1篇)
To assess the association between degenerative joint diseases (DJD) and dementia risk and to identify potential proteomic mediators. We conducted a prospective cohort study using data from 500,805 participants in the UK Biobank. Three DJD diagnoses (osteoarthritis [OA], intervertebral disc degeneration [IVDD], and degenerative spinal diseases [DSD]) were identified from the clinical records. Dementia outcomes (all-cause dementia [ACD], Alzheimer's disease [AD], and vascular dementia [VaD]) were tracked over 14.45 years. Multivariable Cox regression models were used to assess DJD-dementia associations, adjusted for demographics, lifestyle, and comorbidities. Propensity score matching (PSM) was employed for validation. Plasma proteomic profiling of 2,923 proteins was performed to identify potential mediators, followed by causal mediation analysis. After a median follow-up of 14.45 years, 9,884 participants developed ACD, including 4,404 with AD and 2,224 with VaD. After adjusting for covariates, the DJD group exhibited a significantly elevated risk of ACD (HR: 1.271, 95 % CI: 1.173-1.376) and VaD (HR: 1.587, 95 % CI: 1.323-1.903), but not AD (HR: 1.107, 95 % CI: 0.982-1.248). Subgroup analyses revealed significant effect modifications according to age, activity levels, and surgical procedures. PSM analyses confirmed the robustness of these associations. Proteomic analysis identified plasma proteins associated with both DJDs and ACD risk. Mediation analysis revealed that 18 proteins, including HAVCR1 (mediation proportion 52.6 %, 95 % CI: 39.1 %-78 %), GDF15 (22 %, 95 % CI: 14.5 %-46.8 %), and COL6A3 (14.3 %, 95 % CI: 7.7 %-28.4 %), significantly mediated the association between DJDs and ACD. DJDs are independently associated with an increased risk of developing dementia. This correlation is mediated by systemic proteomic alterations. Our findings highlight inflammation and vascular dysfunction as central mechanisms, offering insights into risk stratification and therapeutic targets for preventing dementia.
中文摘要:旨在评估退行性关节疾病(DJD)与痴呆风险之间的关联,并识别潜在的血浆蛋白质组学中介因素。我们利用英国生物银行500,805名参与者的数据开展前瞻性队列研究。从临床记录中识别出三种DJD诊断(骨关节炎[OA]、椎间盘退变[IVDD]和退行性脊柱疾病[DSD])。在14.45年期间追踪痴呆结局(全因痴呆[ACD]、阿尔茨海默病[AD]和血管性痴呆[VaD])。采用多变量Cox回归模型评估DJD与痴呆的关联,并校正人口学、生活方式和合并症。使用倾向评分匹配(PSM)进行验证。对2,923种蛋白质进行血浆蛋白质组学分析以识别潜在中介因素,随后进行因果中介分析。中位随访14.45年后,9,884名参与者发生ACD,其中4,404例为AD,2,224例为VaD。校正协变量后,DJD组发生ACD(HR:1.271,95%CI:1.173-1.376)和VaD(HR:1.587,95%CI:1.323-1.903)的风险显著升高,但AD风险未显著升高(HR:1.107,95%CI:0.982-1.248)。亚组分析显示,年龄、活动水平和手术操作存在显著效应修饰。PSM分析证实了这些关联的稳健性。蛋白质组学分析识别出与DJD和ACD风险均相关的血浆蛋白。中介分析显示,包括HAVCR1(中介比例52.6%,95%CI:39.1%-78%)、GDF15(22%,95%CI:14.5%-46.8%)和COL6A3(14.3%,95%CI:7.7%-28.4%)在内的18种蛋白质显著中介了DJD与ACD之间的关联。DJD与痴呆发生风险升高独立相关。这种相关性由全身蛋白质组学改变所中介。我们的发现突出炎症和血管功能障碍是核心机制,为风险分层和预防痴呆的治疗靶点提供了见解。
基础研究 (10篇)
Abnormal remodeling of subchondral bone (SB), driven by osteoclast sealing zone formation and insufficient adaptation to joint mechanical stress, accelerates the progression of osteoarthritis (OA) and remains a major therapeutic challenge. Here, we developed a mechanically self-reinforcing injectable hydrogel in which amino-hydroxyapatite (amHap)-encapsulating spindle-shaped tellurium (Te) nanoparticles (Te@amHap, Team) were embedded within an oxidized alginate-gelatin matrix (Te@amHap/OG Gel, Team Gel). Team Gel contains dynamic Schiff base bonds, enabling controlled release of Team under joint mechanical forces. Within the acidic microenvironment of the osteoclast sealing zone, Team degrades and releases Te to be oxidized into TeO3 2- by osteoclast-derived H2O2. These ions can react with the thiol-containing residues of F-actin to form Te─S bonds, leading to F-actin degradation to disrupt the sealing zone and suppress bone resorption. Notably, Ca2+ from amHap interacts with alginate to form an egg-box secondary crosslinking structure, enhancing the crosslinking density beyond the original Schiff base network, thereby enhancing the mechanical strength of Team Gel and extending its retention time. Acting together, PO4 3 --mediated inhibition of osteoclast differentiation and Te-driven disruption of the mature osteoclast sealing zone suppress osteoclastogenesis and bone resorption. This sealing zone disruption strategy preserves bone quality and joint integrity, suggesting a promising osteoclast-targeted therapy for OA.
中文摘要:由破骨细胞封闭区形成和对关节机械应力适应不足所驱动的软骨下骨异常重塑会加速骨关节炎进展,并且仍是一项重大治疗挑战。在此,我们开发了一种机械自增强可注射水凝胶,其中以氨基羟基磷灰石(amHap)包封纺锤形碲(Te)纳米颗粒(Te@amHap,Team),并将其嵌入氧化海藻酸钠-明胶基质中(Te@amHap/OG Gel,Team Gel)。Team Gel含有动态席夫碱键,可在关节机械力作用下控制释放Team。在破骨细胞封闭区的酸性微环境中,Team降解并释放Te,Te被破骨细胞来源的H2O2氧化为TeO3 2-。这些离子可与F-肌动蛋白的含巯基残基反应形成Te─S键,导致F-肌动蛋白降解,从而破坏封闭区并抑制骨吸收。值得注意的是,amHap中的Ca2+与海藻酸盐相互作用形成蛋盒状二级交联结构,使交联密度高于原始席夫碱网络,从而增强Team Gel的机械强度并延长其滞留时间。协同作用时,PO4 3--介导的破骨细胞分化抑制和Te驱动的成熟破骨细胞封闭区破坏可抑制破骨细胞生成和骨吸收。这种破坏封闭区的策略可保留骨质量和关节完整性,提示其是一种有前景的靶向破骨细胞的骨关节炎治疗方法。
While osteoarthritis (OA) has traditionally been viewed as a localized joint disorder, systemic metabolic dysfunction is increasingly recognized as a key contributor to its pathogenesis. Here, we identify a liver-cartilage micronutrient axis in which hepatic dysfunction promotes OA through impaired selenium (Se) metabolism. Nationwide cohorts reveal elevated OA prevalence among individuals with liver disease. In murine models of acute and chronic liver injury and metabolic dysfunction-associated steatohepatitis (MASH), hepatic dysfunction disrupts the selenoprotein P (SELENOP)-ApoER2 axis, compromising Se delivery to cartilage. Mechanistically, hepatic stress reduces hepatocyte SELENOP output through convergent transcriptional repression and translational suppression via ribosome collision on selenocysteine (Sec)-rich SELENOP transcripts. The resulting cartilage selenoprotein deficiency promotes chondrocyte senescence, exacerbating OA. Inorganic Se supplementation bypasses impaired SELENOP-mediated Se delivery, restoring chondrocyte selenoproteins and alleviating OA, highlighting Se as a nutritionally modifiable factor. Our findings suggest preventive strategies against joint comorbidity in the growing population with metabolic liver disease.
中文摘要:虽然骨关节炎(OA)传统上被视为一种局部关节疾病,但全身代谢功能障碍日益被认为是其发病机制的关键促成因素。在此,我们识别出一条肝脏-软骨微量营养素轴,其中肝功能异常通过硒(Se)代谢受损促进OA。全国性队列显示,肝病患者中OA患病率升高。在急性与慢性肝损伤以及代谢功能障碍相关脂肪性肝炎(MASH)的小鼠模型中,肝功能异常破坏硒蛋白P(SELENOP)-ApoER2轴,损害硒向软骨的递送。机制上,肝脏应激通过汇聚的转录抑制以及对富含硒代半胱氨酸(Sec)的SELENOP转录本发生核糖体碰撞所致的翻译抑制,降低肝细胞SELENOP输出。由此导致的软骨硒蛋白缺乏促进软骨细胞衰老,加重OA。无机硒补充可绕过受损的SELENOP介导的硒递送,恢复软骨细胞硒蛋白并缓解OA,突显硒作为一种营养上可调控的因素。我们的发现提示,针对日益增长的代谢性肝病人群中的关节共病,可采取预防策略。
Spatial transcriptomics reveals microenvironmental heterogeneity in osteoarthritic subchondral bone.
Although increasing evidence implicates subchondral bone alterations in osteoarthritis, the spatial organization of subchondral bone remodeling remains unclear. Applying spatial transcriptomics to human subchondral bone, we identify a spatially conserved osteogenic core-halo architecture that displays transcriptional reprogramming in sclerotic microenvironments. Spatial dependency and a customized cell-cell communication framework reveal disrupted osteoblast-osteoclast spatial coupling, enhanced osteoblast-mesenchymal interactions, and identify FN1-SDC2 and COL1A1-DDR2 as candidate stromal-osteogenic signaling axes that may contribute to aberrant bone remodeling. Additionally, we present the in situ transcriptional landscape of osteocytes and reveal its potential regulatory role in aberrant bone remodeling. We further delineate a continuum of spatial ecotypes exhibiting distinct enrichment, spatial topology reorganization, and inter-ecotype communication rewiring across pathological states. Metabolic flux inference additionally reveals substrate-limited, stressed states across multiple ecotypes in sclerotic microenvironments. Collectively, our findings provide critical insights into aberrant subchondral bone remodeling in osteoarthritis and offer a valuable framework for future mechanistic studies and therapeutic exploration.
中文摘要:尽管越来越多证据表明软骨下骨改变参与骨关节炎,但软骨下骨重塑的空间组织仍不清楚。我们将空间转录组学应用于人软骨下骨,识别出一个空间上保守的成骨核心-晕轮结构,其在硬化微环境中表现出转录重编程。空间依赖性以及一个定制的细胞间通讯框架揭示了成骨细胞-破骨细胞空间耦合受损、成骨细胞-间充质相互作用增强,并鉴定出FN1-SDC2和COL1A1-DDR2为可能促成异常骨重塑的候选基质-成骨信号轴。此外,我们呈现了骨细胞的原位转录景观,并揭示其在异常骨重塑中的潜在调控作用。我们进一步描绘了一个空间生态型连续谱,其在不同病理状态中表现出不同的富集、空间拓扑重组以及生态型间通讯重连。代谢通量推断还揭示了硬化微环境中多种生态型存在底物受限的应激状态。总体而言,我们的发现为骨关节炎中异常软骨下骨重塑提供了关键见解,并为未来机制研究和治疗探索提供了有价值的框架。
Knee osteoarthritis (KOA) is a whole-joint disease involving the synovium, articular cartilage, subchondral bone, and infrapatellar fat pad. Immune responses contribute to its onset and progression. As immune cell composition and functional states change across disease stages and tissue environments, cytokine sources, activity, and effects also vary over time and among tissues. Most studies have examined individual immune cell types, cytokines, or joint tissues in isolation, limiting their ability to explain the diversity of KOA clinical phenotypes and the variable outcomes of cytokine-targeted treatment. This review examines the spatiotemporal heterogeneity of immune cells in KOA. It traces immune susceptibility and early activation, persistent inflammation and disease progression, and late-stage immune remodeling. It also compares immune microenvironments and cytokine effects in the synovium, articular cartilage, subchondral bone, and infrapatellar fat pad. The review then evaluates IL-1, TNF, IL-6, oncostatin M, colony-stimulating factors, and chemokines as therapeutic targets, considering their roles at different stages, the patients most likely to benefit, and the supporting treatment evidence. Emerging strategies, including modulation of immune cell recruitment and cytokine maturation, sustained local delivery, and gene therapy, are also discussed. Current evidence suggests that the effects of a given cytokine depend in part on its cellular source, the responding tissue, and the disease stage. These differences may help explain why inflammation, structural damage, and pain do not always progress together in KOA. Future studies should combine longitudinal sampling, analysis of multiple joint tissues, and single-cell and spatial omics to identify the predominant immune states in different patients and guide the selection of therapeutic targets, delivery methods, and treatment timing.
中文摘要:膝关节骨关节炎(KOA)是一种累及滑膜、关节软骨、软骨下骨和髌下脂肪垫的全关节疾病。免疫反应参与其发生和进展。由于免疫细胞组成和功能状态随疾病阶段和组织环境而变化,细胞因子的来源、活性及效应也随时间及组织不同而变化。多数研究将单个免疫细胞类型、细胞因子或关节组织孤立地加以研究,这限制了其解释KOA临床表型多样性以及细胞因子靶向治疗结局差异的能力。本综述探讨KOA中免疫细胞的时空异质性。它追溯免疫易感性与早期激活、持续性炎症与疾病进展以及晚期免疫重塑。它还比较滑膜、关节软骨、软骨下骨和髌下脂肪垫中的免疫微环境及细胞因子效应。随后,本综述评估IL-1、TNF、IL-6、制瘤素M、集落刺激因子和趋化因子作为治疗靶点,考虑其在不同阶段的作用、最可能获益的患者以及支持性治疗证据。还讨论了新兴策略,包括调节免疫细胞募集和细胞因子成熟、持续局部递送和基因治疗。当前证据提示,特定细胞因子的效应部分取决于其细胞来源、应答组织及疾病阶段。这些差异可能有助于解释为何KOA中炎症、结构损伤和疼痛并不总是同步进展。未来研究应结合纵向采样、多关节组织分析以及单细胞和空间组学,以识别不同患者中占主导的免疫状态,并指导治疗靶点、递送方式和治疗时机的选择。
Extracellular vesicles (EVs) are emerging as key mediators of disease-associated intercellular communication and as promising biomarker sources across many disease conditions, including joint disorders such as rheumatoid arthritis (RA) and osteoarthritis (OA). Molecular profiling of synovial tissue has uncovered disease-driving cellular states, but tissue biopsies are invasive and not routinely available. EVs in synovial fluid may offer a minimally invasive and complementary window into joint pathobiology. However, the molecular complexity of synovial fluid and the heterogeneity of EV populations have hindered the analysis of defined disease-relevant EV subsets. To address this challenge, we developed a refined size-exclusion chromatography-ultrafiltration (SEC-UF) workflow coupled to magnetic bead-based immunocapture for targeted enrichment of cell type-associated EV subpopulations from arthritic synovial fluid. As proof-of-concept, we targeted a stromal-associated EV population using CD90/THY1, a surface marker expressed by discrete synovial fibroblasts subsets implicated in arthritis pathobiology. In vitro validation using synovial fibroblast-derived EVs confirmed surface-accessible CD90 and demonstrated selective immunocapture of defined EV subpopulations. Application to patient-derived synovial fluid showed that SEC-UF pre-enrichment improves the robustness of CD90+ EV recovery from this complex biofluid. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) profiling established broad EV-associated proteome coverage in synovial fluid (SF)-EV preparations and identified multiple proteins reflecting the inflamed arthritic synovial environment. Fraction-resolved proteomics enabled comparison of the CD90-immunocaptured SF-EV subset with the non-captured CD90-/CD90low SF-EV pool. Differential proteomics and surfaceome-informed cell-of-origin analysis supported enrichment of stromal-associated surface markers in the CD90+ fraction, whereas the non-captured SF-EV pool retained broader immune-associated and residual stromal EV inputs. Together, this fit-for-purpose workflow provides a strategy to resolve EV heterogeneity patient synovial fluid and supports future biomarker-oriented studies of defined subpopulations in arthritic diseases.
中文摘要:细胞外囊泡(EVs)正逐渐成为疾病相关细胞间通讯的关键介质,并作为有前景的生物标志物来源,见于许多疾病状况,包括类风湿关节炎(RA)和骨关节炎(OA)等关节疾病。滑膜组织的分子图谱已揭示驱动疾病的细胞状态,但组织活检具有侵入性且并非常规可获取。滑液中的EVs可能为了解关节病理生物学提供一个微创且互补的窗口。然而,滑液的分子复杂性以及EV群体的异质性阻碍了对特定疾病相关EV亚群的分析。为应对这一挑战,我们开发了一种改进的尺寸排阻色谱-超滤(SEC-UF)流程,并将其与基于磁珠的免疫捕获相结合,用于从关节炎滑液中有针对性地富集与细胞类型相关的EV亚群。作为概念验证,我们使用CD90/THY1靶向一个与基质相关的EV群体;CD90/THY1是一种表面标志物,由与关节炎病理生物学有关的特定滑膜成纤维细胞亚群表达。使用滑膜成纤维细胞来源EVs的体外验证证实了CD90的表面可及性,并证明可对特定EV亚群进行选择性免疫捕获。应用于患者来源的滑液表明,SEC-UF预富集提高了从这种复杂生物流体中回收CD90+ EV的稳健性。液相色谱-串联质谱(LC-MS/MS)分析在滑液(SF)-EV制品中建立了广泛的EV相关蛋白质组覆盖,并鉴定出多种反映炎症性关节炎滑膜环境的蛋白质。按组分解析的蛋白质组学使得可将CD90免疫捕获的SF-EV亚群与未捕获的CD90-/CD90low SF-EV池进行比较。差异蛋白质组学和基于表面蛋白组的细胞来源分析支持CD90+组分中基质相关表面标志物的富集,而未捕获的SF-EV池则保留了更广泛的免疫相关和残余基质EV来源。总之,这一适用性工作流程提供了一种解析患者滑液中EV异质性的策略,并支持未来针对关节炎疾病中特定亚群的生物标志物导向研究。
Osteoarthritis (OA) is a degenerative condition primarily manifested through joint pain. Traditional delivery systems often exhibit numerous side effects. In recent years, light-activated polysaccharide hydrogels with rapid and stable phase transition properties and excellent biocompatibility have served as an ideal platform for controllable local drug delivery and effective tissue regeneration in OA treatment. However, a systematic review of light-activated polysaccharide hydrogels for OA repair is still lacking. This review firstly summarizes the structural regulation and gelation principle of light-activated polysaccharide hydrogels for OA repair, followed by their controlled release property, and therapeutic mechanism. This review establishes a framework for light-activated polysaccharide hydrogels in OA repair. In the design of light-activated polysaccharide hydrogels, the density of polysaccharide functional groups (i.e., -NH2, -OH and -COOH) governs the grafting of light-responsive moieties, which in turn dictates crosslinking density and mechanical properties. The photothermal materials and modifications to the polysaccharide hydrogels collaboratively regulate release kinetics, while the different delivery formats could meet specific therapeutic requirements in OA treatment. However, more development and research are needed to extensively explore long-term safety, mechanical strength, and photocuring depth of these light-activated polysaccharide hydrogels.
中文摘要:骨关节炎(OA)是一种主要以关节疼痛为表现的退行性疾病。传统递送系统常表现出诸多副作用。近年来,具有快速且稳定相变特性以及优异生物相容性的光激活多糖水凝胶,已成为骨关节炎治疗中可控局部药物递送和有效组织再生的理想平台。然而,尚缺乏针对用于OA修复的光激活多糖水凝胶的系统综述。本综述首先总结了用于OA修复的光激活多糖水凝胶的结构调控与成胶原理,随后介绍其控释特性及治疗机制。本综述为光激活多糖水凝胶在OA修复中的应用建立了框架。在光激活多糖水凝胶的设计中,多糖官能团(即-NH2、-OH和-COOH)的密度决定光响应部分的接枝,进而决定交联密度和力学性能。光热材料与多糖水凝胶的修饰共同调控释放动力学,而不同的递送形式可满足OA治疗中的特定治疗需求。然而,仍需要更多开发和研究来广泛探索这些光激活多糖水凝胶的长期安全性、力学强度和光固化深度。
Beyond their canonical role in bioenergetics, mitochondria are now recognized as critical signaling platforms that orchestrate innate immune responses. Central to this function is mitochondrial dynamics-the controlled equilibrium between fission and fusion-which serves as a critical structural and thermodynamic checkpoint for cellular fate and immunological status. A substantial body of evidence indicates that pathological mitochondrial fission, frequently driven by Dynamin-related protein 1 (Drp1), is a hallmark of numerous inflammatory conditions. Mechanistically, fragmented mitochondria release damage-associated molecular patterns (DAMPs) and induce acute ATP suppression, metabolically "licensing" NLRP3 activation by collapsing the ATP hydrolysis potential (ΔGATP). Recent breakthroughs have redefined this axis, distinguishing between physical damage and metabolic triggers, such as pyrimidine imbalance via the YME1L-SLC25A33 axis. Furthermore, the immunogenicity of DAMPs is strictly context-dependent; oxidized or "fragile" mtDNA containing ribonucleotides act as hyper-immunogenic ligands for cytosolic sensors like cGAS-STING. Emerging evidence further highlights that endosomal-mitochondrial crosstalk, intercellular mitochondrial transfer, and lipid-driven metabolic rewiring profoundly govern macrophage polarization and tissue homeostasis. Conversely, promoting mitochondrial fusion and robust quality control preserves organellar integrity and attenuates inflammatory cascades. This review critically synthesizes current literature, deconstructing the molecular linkages between organelle structure and metabolic signaling. By exploring the consequences in sepsis, neuroinflammation, osteoarthritis, and cancer, this treatise evaluates the pharmacological potential of modulating mitochondrial dynamics-ranging from direct Drp1 inhibitors and unfractionated heparin to metabolic stabilizers (e.g., GLP-1 receptor agonists), multi-pronged disruptors (e.g., Antimycin A), targeted nanomedicine, and communication-driven mitochondrial transplantation-positioning this axis as a promising frontier for precision pharmacology.
中文摘要:除了在生物能量学中的经典作用外,线粒体现已被认为是协调先天免疫反应的关键信号平台。这一功能的核心是线粒体动力学——裂变与融合之间的受控平衡——它作为细胞命运和免疫状态的关键结构和热力学检查点。大量证据表明,病理性线粒体裂变通常由动力相关蛋白1(Drp1)驱动,是众多炎症状况的标志。在机制上,破碎的线粒体释放损伤相关分子模式(DAMPs)并诱导急性ATP抑制,通过破坏ATP水解潜能(ΔGATP)在代谢上「许可」NLRP3激活。近期突破重新定义了该轴,区分了物理损伤和代谢触发因素,例如通过YME1L-SLC25A33轴的嘧啶失衡。此外,DAMPs的免疫原性严格依赖于背景;含有核糖核苷酸的氧化或「脆弱」mtDNA作为高免疫原性配体作用于胞质传感器如cGAS-STING。新出现的证据进一步强调,内体-线粒体串扰、细胞间线粒体转移和脂质驱动的代谢重编程深刻调控巨噬细胞极化和组织稳态。相反,促进线粒体融合和稳健的质量控制可保持细胞器完整性并减弱炎症级联反应。本综述批判性综合当前文献,解构细胞器结构与代谢信号之间的分子联系。通过探讨在脓毒症、神经炎症、骨关节炎和癌症中的后果,本文评估调节线粒体动力学的药理学潜力——从直接Drp1抑制剂和普通肝素到代谢稳定剂(如GLP-1受体激动剂)、多靶点干扰剂(如抗霉素A)、靶向纳米医学和通讯驱动的线粒体移植——将该轴定位为精准药理学有前景的前沿。
Osteoarthritis (OA) is a common age-associated joint disorder driven not only by mechanical wear but also by progressive intracellular stress, metabolic imbalance, and chronic inflammation that culminate in cartilage degeneration and functional disability. Increasing evidence identifies mitochondrial dysfunction and endoplasmic reticulum stress (ERS) as central pathological hubs regulating chondrocyte survival, extracellular matrix (ECM) integrity, and inflammatory signaling. Mitochondrial impairment promotes excessive reactive oxygen species (ROS) generation, defective ATP production, disturbed mitochondrial dynamics, and inadequate mitophagy, collectively accelerating ECM catabolism and chondrocyte apoptosis. In parallel, ERS activates the unfolded protein response (UPR) to restore proteostasis through the PERK, IRE1α, and ATF6 pathways; however, sustained UPR activation shifts from adaptive signaling to maladaptive outcomes, amplifying inflammation, oxidative injury, and cell death in OA cartilage. Notably, emerging data highlight bidirectional crosstalk between mitochondria and ER, particularly via mitochondria-associated membranes (MAMs), as a key driver of Ca²⁺ dysregulation, inflammasome activation, and degenerative joint remodeling. Therapeutic strategies targeting these stress pathways including mitochondrial antioxidants, NAD⁺-boosting agents, mitophagy modulators, chemical chaperones, and selective UPR regulators have demonstrated potential to attenuate cartilage destruction and restore joint homeostasis. This review synthesizes current mechanistic insights into mitochondrial ERS signaling in OA and critically evaluates evolving disease-modifying interventions aimed at intracellular stress reprogramming. Finally, we discuss translational challenges and future directions for developing precision therapies that exploit organelle stress pathways to improve long-term joint health.
中文摘要:骨关节炎(OA)是一种常见的与年龄相关的关节疾病,其驱动因素不仅包括机械磨损,还包括进行性细胞内应激、代谢失衡和慢性炎症,最终导致软骨退变和功能残疾。越来越多证据表明,线粒体功能障碍和内质网应激(ERS)是调控软骨细胞存活、细胞外基质(ECM)完整性和炎症信号的核心病理枢纽。线粒体损伤可促进活性氧(ROS)过度生成、ATP产生缺陷、线粒体动力学紊乱和线粒体自噬不足,共同加速ECM分解代谢和软骨细胞凋亡。与此同时,ERS激活未折叠蛋白反应(UPR),通过PERK、IRE1α和ATF6通路恢复蛋白质稳态;然而,持续UPR激活会从适应性信号转向适应不良结局,放大OA软骨中的炎症、氧化损伤和细胞死亡。值得注意的是,新近数据强调线粒体与内质网之间的双向串扰,特别是通过线粒体相关膜(MAMs),是Ca²⁺失调、炎症小体激活和退变性关节重塑的关键驱动因素。针对这些应激通路的治疗策略,包括线粒体抗氧化剂、NAD⁺增强剂、线粒体自噬调节剂、化学伴侣和选择性UPR调节剂,已显示具有减轻软骨破坏和恢复关节稳态的潜力。本综述综合了当前关于OA中线粒体-ERS信号机制的见解,并批判性评估了旨在重编程细胞内应激的新兴疾病修饰干预措施。最后,我们讨论了利用细胞器应激通路开发精准治疗以改善长期关节健康的转化挑战和未来方向。
Retinoids comprise vitamin A and its structurally related natural and synthetic derivatives. Retinoid dynamics involves multiple retinoid forms, carrier proteins, and enzymes that orchestrate the absorption, transport, storage and biotransformation of dietary vitamin A. Beyond their canonical metabolic functions, metabolites and proteins involved in retinoid metabolism also play distinct roles in signal transduction and transcriptome reprogramming, broadening the mechanisms that influence immune cell fate decisions. Age‑related changes in retinoid bioavailability and signaling intensity alter immune cell polarization and function, thereby contributing to the pathogenesis of chronic inflammation in neurodegenerative diseases, cardiovascular diseases, osteoarthritis, and other age-related diseases. In this review, we focus on age-related alterations in the retinoid metabolic pathway and their impact on inflammation and the progression of age-related diseases. This review highlights the pivotal role of retinoid metabolism in anti-ageing interventions and considers future directions and challenges in this field.
中文摘要:类视黄醇包括维生素A及其结构相关的天然和合成衍生物。类视黄醇动态涉及多种类视黄醇形式、载体蛋白和酶,它们协调膳食维生素A的吸收、转运、储存和生物转化。除了经典的代谢功能外,参与类视黄醇代谢的代谢物和蛋白质还在信号转导和转录组重编程中发挥独特作用,从而拓展了影响免疫细胞命运决定的机制。与年龄相关的类视黄醇生物利用度和信号强度变化会改变免疫细胞极化和功能,进而促进神经退行性疾病、心血管疾病、骨关节炎及其他年龄相关疾病中慢性炎症的发病机制。在本综述中,我们关注类视黄醇代谢通路的年龄相关改变及其对炎症和年龄相关疾病进展的影响。本综述强调类视黄醇代谢在抗衰老干预中的关键作用,并思考该领域的未来方向与挑战。
Mechanical cues from the extracellular matrix (ECM) are critical regulators of chondrocyte behavior and cartilage homeostasis. Mechanical confinement, determined by the stress relaxation properties of the surrounding matrix, can drive anabolic ECM production or catabolic activity. However, the intracellular signaling pathways linking confinement to ECM remodeling remain poorly defined. Here, alginate hydrogels with tunable stress relaxation properties were used to investigate how confinement regulates signaling and matrix production. Low-confinement, fast-relaxing matrices promoted ECM deposition, whereas high-confinement, slow-relaxing matrices increased inflammatory and catabolic gene expression. Kinase activity profiling identified mitogen-activated protein kinase (MAPK) signaling as a key pathway modulated by confinement, with subsequent activation of Hedgehog (Hh) signaling. Pharmacological activation of Hh signaling enhanced matrix deposition and restored chondrogenic morphology in low-confinement conditions. ECM formation negatively correlated with primary cilia length, and confinement-mediated changes in chondrocyte volume occurred even without primary cilia. These findings support a model in which confinement regulates matrix production via MAPK and Hh signaling to maintain homeostasis, with alterations in confinement, such as those in osteoarthritis or aging, linked to changes in chondrocyte phenotype. This work positions confinement as a central regulator of cartilage mechanobiology and provides design principles for viscoelastic biomaterials supporting balanced ECM remodeling.
中文摘要:来自细胞外基质(ECM)的机械线索是软骨细胞行为和软骨稳态的关键调节因素。机械限域由周围基质的应力松弛特性决定,可驱动合成代谢性ECM生成或分解代谢活性。然而,将限域与ECM重塑联系起来的细胞内信号通路仍不明确。在此,采用具有可调应力松弛特性的藻酸盐水凝胶研究限域如何调节信号传导和基质生成。低限域、快速松弛的基质促进ECM沉积,而高限域、缓慢松弛的基质增加炎症和分解代谢基因表达。激酶活性谱分析确定丝裂原活化蛋白激酶(MAPK)信号是受限域调节的关键通路,随后激活Hedgehog(Hh)信号。药理学激活Hh信号可增强基质沉积,并在低限域条件下恢复软骨形成形态。ECM形成与初级纤毛长度呈负相关,并且限域介导的软骨细胞体积变化即使在无初级纤毛时也会发生。这些发现支持一个模型:限域通过MAPK和Hh信号调节基质生成以维持稳态,而限域的改变,如骨关节炎或衰老中的改变,与软骨细胞表型变化相关。这项工作将限域定位为软骨力学生物学的中心调节因素,并为支持平衡ECM重塑的黏弹性生物材料提供了设计原则。
3生物材料/植入物 (8篇)
基础研究 (8篇)
Osteomyelitis is a severe orthopedic infection that demands advanced biomaterial-based strategies for local infection control and bone defect management. Calcium-phosphate-based hydroxyapatite (HAp) is widely used for bone regeneration due to its compositional similarity to natural bone; however, poor mechanical and antibacterial properties limit its performance. In the present study, Zn-Fe-containing biphasic calcium phosphate (ZFHAp) nanomaterials, composed of Calcium Iron Hydrogen Phosphate (CIHP) (69.86%) and Parascholzite (PS) (30.14%), were incorporated into 3D chitosan scaffolds to fabricate multifunctional porous constructs. Nanomaterials incorporation enhanced the elastic modulus (Emod) from 70 kPa to 996 kPa (6 wt%), within the lower range of cancellous bone stiffness. The scaffolds exhibited rapid swelling (up to 1.4 min-1) and first-order enzymatic degradation, with rates ranging from 0.0047 to 0.0148 day-1. Sustained Zn2+ and Fe3+ release over 7 days correlated with >80% growth inhibition of S. aureus and E. coli, while maintaining the acceptable cytocompatibility of MG-63 cells. Structure-property analysis indicated a nonlinear relationship between nanomaterial loading and mechanical performance, with parabolic fitting suggesting an optimal composition of 5-6 wt% for balanced modulus and cell surface coverage. Overall, these chitosan-ZFHAp composite scaffolds demonstrate tunable mechanical properties, controlled degradation, antibacterial activity, and cytocompatibility, supporting their potential as multifunctional scaffolds for bone-related defect management.
中文摘要:骨髓炎是一种严重的骨科感染,需要先进的基于生物材料的策略来实现局部感染控制和骨缺损处理。基于磷酸钙的羟基磷灰石(HAp)因其组成与天然骨相似而被广泛用于骨再生;然而,较差的力学性能和抗菌性能限制了其应用表现。在本研究中,含Zn-Fe的双相磷酸钙(ZFHAp)纳米材料由磷酸氢铁钙(CIHP)(69.86%)和Parascholzite(PS)(30.14%)组成,被掺入三维壳聚糖支架中以制备多功能多孔构建体。纳米材料的掺入使弹性模量(Emod)从70 kPa提高到996 kPa(6 wt%),处于松质骨刚度的较低范围内。支架表现出快速溶胀(最高达1.4 min-1)和一级酶促降解,降解速率范围为0.0047至0.0148 day-1。在7天内持续释放Zn2+和Fe3+与对金黄色葡萄球菌和大肠杆菌的生长抑制率超过80%相关,同时保持MG-63细胞可接受的细胞相容性。结构-性能分析表明,纳米材料负载量与力学性能之间呈非线性关系,抛物线拟合提示5-6 wt%为兼顾模量和细胞表面覆盖的最佳组成。总体而言,这些壳聚糖-ZFHAp复合支架表现出可调控的力学性能、可控降解、抗菌活性和细胞相容性,支持其作为骨相关缺损处理的多功能支架的潜力。
Herein, soybean protein isolate (SPI) and dialdehyde sodium alginate (DSA) were employed as model systems to investigate the formation mechanism of Schiff base hydrogels and their performance regulation under varying alkaline pH conditions (7.0-11.5). Spectral analysis indicated that as pH increased, the SPI conformation gradually unfolded, exposing amino acid residues and enhancing Schiff base cross-linking. The cross-linking degree of the hydrogel at pH 10.5 reached 3.6 times that observed at pH 7.0. However, under strongly alkaline conditions (pH 11.5), SPI and DSA underwent degradation, leading to a localized over-crosslinking of the hydrogel and a reduction in toughness, resulting in brittle fracture occurring near 60% strain. Comprehensive evaluation of macroscopic/microscopic structure, rheology, mechanical properties, swelling and degradation behavior revealed that SPI/DSA hydrogels with optimal overall performance can be obtained at pH 10.5. Finally, molecular dynamics simulations further showed that glycinin (11S) exhibited strong binding stability with DSA.
中文摘要:本文以大豆分离蛋白(SPI)和二醛海藻酸钠(DSA)为模型体系,研究席夫碱水凝胶的形成机制及其在不同碱性pH条件(7.0–11.5)下的性能调控。光谱分析表明,随着pH升高,SPI构象逐渐展开,暴露出氨基酸残基并增强席夫碱交联。pH 10.5时水凝胶的交联度达到pH 7.0时的3.6倍。然而,在强碱性条件(pH 11.5)下,SPI和DSA发生降解,导致水凝胶局部过度交联、韧性下降,并在约60%应变附近发生脆性断裂。对宏观/微观结构、流变学、力学性能、溶胀和降解行为的综合评价表明,在pH 10.5时可获得综合性能最佳的SPI/DSA水凝胶。最后,分子动力学模拟进一步显示,大豆球蛋白(11S)与DSA具有较强的结合稳定性。
Natural load-bearing tissues such as tendon exhibit both high stiffness and toughness owing to their densely packed, hierarchical architectures. However, most synthetic hydrogels suffer from biomechanical mismatch and lack of biocompatibility, which restrict their utility in tendon-related therapy. In this work, we report a set of glassy, poly(vinyl alcohol) hydrogels, stiffened and toughened through salting-out with a super-kosmotropic salt, sodium hexametaphosphate. The highly-charged anion displays an exceptional B-coefficient of 1.408 L mol-1 with remarkable kosmotropic effect, which not only promotes the formation of crystalline domains but also immobilizes free water molecules within gel networks. The resultant materials are endowed with substantially enhanced stiffness, toughness and fracture energy of 1061.8 MPa, 548.5 MJ m-3, and 272.5 kJ m-2, respectively, matching those of native tendons. Utilizing these hydrogels as biomechanical scaffolds in a tendon-ruptured rat model demonstrate high efficacy in both morphological and functional recovery. Salting-out biopolymers with super-kosmotropic agents enlightens the design and construction of stiff-yet-tough biomaterials, holding great promise for biomedical applications in regenerative and reparative therapies of natural load-bearing tissues.
中文摘要:天然承重组织如肌腱,由于其致密堆积的层级结构,同时表现出高刚度与高韧性。然而,大多数合成水凝胶存在生物力学失配和生物相容性不足,限制了其在肌腱相关治疗中的应用。在本工作中,我们报道了一类玻璃态聚乙烯醇水凝胶,通过使用超促渗盐六偏磷酸钠进行盐析而实现增刚与增韧。这种高电荷阴离子表现出异常的B系数,为1.408 L mol-1,并具有显著的促渗效应,不仅促进结晶域形成,还固定了凝胶网络中的自由水分子。所得材料具有显著增强的刚度、韧性和断裂能,分别为1061.8 MPa、548.5 MJ m-3和272.5 kJ m-2,与天然肌腱相匹配。将这些水凝胶作为生物力学支架用于肌腱断裂大鼠模型,在形态学和功能恢复方面均表现出高效性。使用超促渗剂对生物聚合物进行盐析,为刚韧兼具生物材料的设计与构建提供了启示,并在天然承重组织的再生与修复治疗中具有广阔生物医学应用前景。
Diabetes mellitus compromises bone regeneration and increases implant failure rates, posing persistent challenges in orthopedic and dental therapies. Although macrophage-centered immunomodulation has been widely investigated, the role of neutrophils, particularly under diabetic conditions, remains insufficiently defined. Here, we identify neutrophil dysfunction, characterized by impaired chemotaxis and elevated oxidative stress, as a critical upstream driver of impaired osseointegration in diabetes. We demonstrate that dietary flavonoid quercetin restores neutrophil redox homoeostasis in association with reactivation of Nrf2/HO-1 signaling, attenuates pathological neutrophil extracellular trap formation, and promotes MerTK-associated efferocytosis by macrophages. Efferocytosis of quercetin-treated neutrophils subsequently reprograms macrophage toward an anti-inflammatory, pro-regenerative M2-like phenotype, therefore establishing a microenvironment favorable for angiogenesis and osteogenesis. Based on these insights, we engineer a biodegradable tri-layered coating on polyetheretherketone (PEEK) implant, comprising an osteoconductive nano-hydroxyapatite base layer, a quercetin-rich antioxidant intermediate layer, and an outermost surface functionalized with the chemotactic peptide formyl-methionyl-leucyl-phenylalanine (fMLP) to actively recruit neutrophils. In a diabetic rat model, this rationally designed interface enables temporal coordination of innate immune responses, leading to substantially improved vascularized bone regeneration and implant osseointegration. These findings highlight neutrophils as key therapeutic targets in diabetic bone repair and propose an immunomodulatory biomaterials strategy that addresses upstream immune dysregulation in compromised metabolic conditions.
中文摘要:糖尿病会损害骨再生并增加植入失败率,给骨科与牙科治疗带来持续挑战。尽管以巨噬细胞为中心的免疫调节已被广泛研究,但中性粒细胞的作用,尤其是在糖尿病条件下,仍未被充分阐明。在此,我们确定中性粒细胞功能障碍,其特征为趋化受损和氧化应激升高,是糖尿病中骨整合受损的关键上游驱动因素。我们证明膳食黄酮类化合物槲皮素可恢复中性粒细胞氧化还原稳态,并与Nrf2/HO-1信号再激活相关,减轻病理性中性粒细胞胞外诱捕网形成,并促进巨噬细胞中MerTK相关的胞葬作用。槲皮素处理的中性粒细胞被胞葬后,进而将巨噬细胞重编程为抗炎、促再生的M2样表型,从而建立有利于血管生成和骨生成的微环境。基于这些发现,我们在聚醚醚酮(PEEK)植入物上构建了一种可生物降解的三层涂层,包括成骨传导性纳米羟基磷灰石底层、富含槲皮素的抗氧化中间层,以及用趋化肽N-甲酰甲硫氨酰-亮氨酰-苯丙氨酸(fMLP)功能化的最外层表面,以主动招募中性粒细胞。在糖尿病大鼠模型中,这一理性设计的界面能够对先天免疫反应进行时间协调,从而显著改善血管化骨再生和植入物骨整合。这些发现突出中性粒细胞是糖尿病骨修复中的关键治疗靶点,并提出一种免疫调节生物材料策略,以应对代谢受损条件下的上游免疫失调。
Magnesium (Mg) alloy screws represent promising biodegradable orthopedic implants owing to their biocompatibility, mechanical strength, and gradual resorption, thereby obviating the need for secondary removal surgery. However, their electrical conductivity raises safety concerns during magnetic resonance imaging (MRI) used for the assessment of healing progress and potential complications, where exposure to radiofrequency (RF) energy may induce tissue heating. As Mg implants degrade, evolving geometry and material phase may alter electromagnetic behavior, deposition of RF energy and potential heating. This study systematically examined the effects of key degradation mechanisms-volume reduction, surface roughening, formation of a magnesium hydroxide layer, and implant fractures-on MRI-induced heating. High-resolution electromagnetic field simulations at 3.0 T (ASTM F2182 phantom and realistic human voxel model) were complemented by thermal modeling and experimental MRI heating measurements using real-world screws. Volume loss and edge smoothing reduced maximum 1g-specific absorption rate (SAR1g) by up to 12%, while surface roughness (RMS = 0.5 mm) reduced SAR1g by -0.28% through increased surface impedance. Degradation layer caused minimal SAR change (<0.5%). Screw fractures increased localized SAR1g by up to 19.1% but redistributed heat more uniformly across the implant, lowering peak temperatures compared to intact screws. In the human voxel model, fractured screws remained below the IEC safety limits under maximum permissible RF exposure with a maximum temperature elevation of 38.9 °C, whereas non-fractured screws exceeded 40 °C. Our results demonstrate that Mg screw degradation generally mitigates MRI heating risks. In conclusion, engineered degradation features may enhance MRI safety, providing design guidance for next-generation biodegradable orthopedic implants.
中文摘要:镁(Mg)合金螺钉是具有前景的可生物降解骨科植入物,因其生物相容性、机械强度和逐步吸收,从而无需二次取出手术。然而,其导电性在用于评估愈合进展和潜在并发症的磁共振成像(MRI)中引发安全性担忧,暴露于射频(RF)能量可能诱使组织加热。随着镁植入物降解,不断变化的几何形状和材料相可能改变电磁行为、RF能量沉积和潜在加热。本研究系统考察了关键降解机制——体积减少、表面粗糙化、氢氧化镁层形成和植入物断裂——对MRI诱导加热的影响。在3.0 T下进行高分辨率电磁场仿真(ASTM F2182体模和真实人体体素模型),并辅以热建模和使用真实螺钉的实验性MRI加热测量。体积损失和边缘平滑使最大1g比吸收率(SAR1g)降低最多12%,而表面粗糙度(RMS = 0.5 mm)通过增加表面阻抗使SAR1g降低-0.28%。降解层导致SAR变化极小(<0.5%)。螺钉断裂使局部SAR1g增加最多19.1%,但使热量在植入物上更均匀地重新分布,与完整螺钉相比降低了峰值温度。在人体体素模型中,断裂螺钉在最大允许RF暴露下仍低于IEC安全限值,最高温升为38.9 °C,而未断裂螺钉超过40 °C。我们的结果表明,镁螺钉降解总体上减轻MRI加热风险。总之,工程化的降解特征可能增强MRI安全性,为下一代可生物降解骨科植入物提供设计指导。
Porous titanium (PT) and its alloys are widely used in orthopedic applications due to their interconnected porosity, favorable mechanical properties, biocompatibility, and low elastic modulus that alleviates stress shielding. However, the long-term clinical success of PT implants is largely determined by their surface characteristics. In recent years, surface functionalization has emerged as a promising strategy for tailoring the physicochemical and biological properties of PT. By constructing bioactive coatings or functional interfaces with controlled composition and microstructure, these approaches can significantly enhance corrosion and wear resistance, often reducing corrosion current density by one to two orders of magnitude. They also exhibit high antibacterial performance, commonly exceeding 90% efficacy against representative bacterial strains, and promote osteogenic responses, with cell adhesion, proliferation, and differentiation generally enhanced compared to unmodified controls, thereby facilitating osseointegration. This review systematically summarizes recent advances in PT surface functionalization, encompassing in-situ modification, coating-based, and pore-filling strategies, with a focus on their mechanisms, applications, and comparative advantages. Furthermore, emerging trends and innovative approaches are discussed, highlighting their potential for developing multifunctional and clinically translatable PT implants. Overall, this review provides an overview of recent progress and remaining challenges, offering guidance for the rational design of next-generation PT implants with enhanced biological performance and clinical applicability.
中文摘要:多孔钛(PT)及其合金因其互联孔隙、良好的力学性能、生物相容性和低弹性模量可减轻应力屏蔽,而被广泛用于骨科应用。然而,PT植入物的长期临床成功在很大程度上取决于其表面特征。近年来,表面功能化已成为定制PT理化与生物学性能的一种有前景的策略。通过构建具有受控组成和微结构的生物活性涂层或功能界面,这些方法可显著增强耐腐蚀和耐磨性能,通常使腐蚀电流密度降低一到两个数量级。它们还表现出高抗菌性能,对代表性菌株的效能通常超过90%,并促进成骨反应,与未改性对照相比,细胞黏附、增殖和分化通常增强,从而有利于骨整合。本综述系统总结了PT表面功能化的近期进展,涵盖原位改性、涂层基策略和孔隙填充策略,重点阐述其机制、应用及比较优势。此外,还讨论了新兴趋势和创新方法,强调其在开发多功能且临床可转化的PT植入物方面的潜力。总体而言,本综述概述了近期进展和仍存挑战,为合理设计具有增强生物学性能和临床适用性的下一代PT植入物提供指导。
Biodegradable metals exhibit heterogeneous degradation patterns within complex physiological microenvironments, which frequently culminate in premature implant sequestration or failure. While traditional research paradigms have prioritized enhancing material homogeneity, the impact of site-specific physiological variability remains insufficiently addressed. This study investigated the degradation kinetics and osteogenic efficacy of Zn-0.8Mg and Zn-0.8Fe alloys implanted into distinct anatomical sites: the medullary cavity and the bone matrix. Our findings reveal that microenvironmental fluctuations trigger macro-galvanic coupling within the Zn alloys, inducing localized crevice corrosion. The spatiotemporal flux of Zn2+ was identified as a decisive factor in modulating bone regeneration. In the well-perfused medullary cavity, the Zn alloy functioned as a cathodic site, exhibiting suppressed degradation rates. This sustained Zn2+ release within a pro-osteogenic therapeutic window, significantly enhancing bone volume; notably, the Zn-0.8Mg alloy elicited a 10-fold increase in new bone formation relative to pure Titanium (Ti) after one month. Conversely, within the transport-restricted bone matrix, the alloy acted as an anode, undergoing accelerated degradation. The resultant Zn2+ overload triggered pro-inflammatory macrophage polarization and impaired osteoblast viability. Histological analysis at one-month post-implantation revealed am non-ossified zone surrounding the implants, measuring approximately 50 μm for Zn-0.8Mg and 100 μm for Zn-0.8Fe. These insights underscore that the implant microenvironment dictates the material's biological fate, providing new understanding for the design of next-generation, microenvironment-adaptive orthopedic implants.
中文摘要:可生物降解金属在复杂生理微环境中表现出异质性降解模式,这常导致植入物过早失效或被隔离。传统研究范式优先提升材料均质性,但位点特异性生理变异的影响仍未得到充分探讨。本研究考察了植入不同解剖部位(髓腔与骨基质)的Zn-0.8Mg和Zn-0.8Fe合金的降解动力学与成骨效能。我们的发现揭示,微环境波动会触发Zn合金内部的宏观电偶耦合,诱发局部缝隙腐蚀。Zn2+的时空通量被确定为调控骨再生的决定性因素。在灌注良好的髓腔中,Zn合金充当阴极位点,降解速率受到抑制。这种在促骨生成治疗窗内持续释放的Zn2+显著增加了骨体积;值得注意的是,与纯钛(Ti)相比,Zn-0.8Mg合金在1个月后使新骨形成增加10倍。相反,在转运受限的骨基质中,合金充当阳极,降解加速。由此产生的Zn2+过载触发促炎性巨噬细胞极化并损害成骨细胞活力。植入后1个月的组织学分析显示,植入物周围存在未骨化区,Zn-0.8Mg约为50 μm,Zn-0.8Fe约为100 μm。这些见解强调,植入物微环境决定材料的生物学命运,为设计下一代微环境自适应骨科植入物提供了新认识。
Diabetic bone defects are not merely a consequence of impaired bone formation, but a complex syndrome driven by chronic hyperglycemia, characterized by dysregulated bone metabolism, vascular impairment, immune imbalance, and notably, aberrant activation of ferroptosis in osteoblasts. These multifaceted pathologies pose a major challenge in orthopedic treatment. In this study, we report the development of a metal-polyphenol synergistic hydrogel platform (HES) designed to address the unique demands of diabetic bone regeneration. Epigallocatechin gallate (EGCG) and strontium ions (Sr2+) are self-assembled into bioactive metal-phenolic network (MPN) nanoparticles (EGCG-Sr2+ NPs), which are uniformly integrated into a three-dimensional hyaluronic acid (HA) hydrogel matrix. This platform achieves spatiotemporal coordination of EGCG-mediated antioxidation and Sr2+-driven angiogenesis, while EGCG chelates metal ions to inhibit ferroptosis by scavenging ROS, sequestering Fe3+, protecting GPX4, upregulating HO-1, and suppressing lipid peroxidation. Additionally, EGCG exerts anti-inflammatory effects, and Sr2+ promotes angiogenesis, collectively enhancing osteogenic differentiation and tissue repair. Overall, this multifunctional hydrogel integrates ferroptosis inhibition, antioxidation, immunomodulation, and osteoinduction, offering a promising therapeutic strategy for effective repair of diabetic bone defects.
中文摘要:糖尿病骨缺损不仅仅是骨形成受损的结果,而是一种由慢性高血糖驱动的复杂综合征,其特征为骨代谢失调、血管损伤、免疫失衡,尤其是成骨细胞中铁死亡异常激活。这些多方面的病理改变给骨科治疗带来了重大挑战。在本研究中,我们报道了一种金属-多酚协同水凝胶平台(HES)的开发,旨在满足糖尿病骨再生的独特需求。表没食子儿茶素没食子酸酯(EGCG)和锶离子(Sr2+)自组装形成具有生物活性的金属-酚网络(MPN)纳米颗粒(EGCG-Sr2+ NPs),并均匀整合到三维透明质酸(HA)水凝胶基质中。该平台实现了EGCG介导的抗氧化与Sr2+驱动的血管生成之间的时空协调,同时EGCG螯合金属离子,通过清除ROS、螯合Fe3+、保护GPX4、上调HO-1和抑制脂质过氧化来抑制铁死亡。此外,EGCG发挥抗炎作用,Sr2+促进血管生成,共同增强成骨分化与组织修复。总体而言,这种多功能水凝胶整合了铁死亡抑制、抗氧化、免疫调节和骨诱导作用,为有效修复糖尿病骨缺损提供了一种有前景的治疗策略。
4骨折/创伤 (3篇)
临床研究 (1篇)
The relationship between socioeconomic status and outcomes after hip fracture surgery remains unclear. We aimed to assess the association between individual-level socioeconomic status indicators and mortality after acute hip fracture surgery in Sweden. Cross-linked registry-based cohort study of patients undergoing acute hip fracture surgery in Sweden 2015-20. Co-primary outcomes were 30-day and 2-yr all-cause mortality. Socioeconomic status was defined using four indicators: level of education, income, residential area, and receipt of social services. Attributable fractions were calculated to illustrate the potential population-level distribution of mortality differences across SES categories. There were 58 641 patients included (median age 83 [interquartile range 75-89] yr, 66.1% women). Crude 30-day and 2-yr mortalities were 7.9% (95% confidence interval [CI] 7.7-8.1) and 35.3% (95% CI 34.9-35.7). Level of education showed the strongest association, with a stepwise gradient most pronounced for 2-yr mortality: adjusted odds ratio 1.16 (95% CI 1.08-1.24) for 10-12 yr, 1.20 (95% CI 1.09-1.32) for 9 yr, and 1.25 (95% CI 1.16-1.34) for <9 yr vs >12 yr (all P<0.001). The attributal fraction for 2-yr mortality was 14.0% (standard error 0.022), with an increase in absolute risk of 6.3% (95% CI 4.3-8.2) for >12 yr vs <9 yr of education. Other socioeconomic status factors, except residential area, were also associated with mortality, although less substantially. Individual socioeconomic status was associated with short- and long-term death after acute hip fracture surgery in Sweden, with education showing the strongest relationship. These findings support consideration of individual-level socioeconomic factors in perioperative hip fracture care at the population level.
中文摘要:社会经济地位与髋部骨折手术后结局之间的关系仍不明确。我们旨在评估瑞典急性髋部骨折手术后个体层面社会经济地位指标与死亡率之间的关联。本研究为一项基于登记系统的交叉链接队列研究,纳入2015—2020年在瑞典接受急性髋部骨折手术的患者。共同主要结局为30天和2年全因死亡率。社会经济地位采用四项指标定义:教育水平、收入、居住地区和接受社会服务情况。计算归因分数,以说明不同社会经济地位类别之间死亡率差异在人群层面的潜在分布。共纳入58 641例患者(中位年龄83岁[四分位距75—89岁],女性占66.1%)。粗30天和2年死亡率分别为7.9%(95%置信区间7.7—8.1)和35.3%(95%置信区间34.9—35.7)。教育水平显示出最强的关联,其阶梯式梯度在2年死亡率中最为明显:与>12年教育相比,10—12年的校正比值比为1.16(95%置信区间1.08—1.24),9年为1.20(95%置信区间1.09—1.32),<9年为1.25(95%置信区间1.16—1.34)(均P<0.001)。2年死亡率的归因分数为14.0%(标准误0.022),与<9年教育相比,>12年教育的绝对风险增加6.3%(95%置信区间4.3—8.2)。除居住地区外,其他社会经济地位因素也与死亡率相关,但关联程度较弱。在瑞典,个体社会经济地位与急性髋部骨折手术后短期和长期死亡相关,其中教育水平表现出最强关联。这些发现支持在人群层面的髋部骨折围手术期照护中考虑个体层面社会经济因素。
基础研究 (2篇)
Large bone defects remain a major clinical challenge, as current treatments cannot effectively regenerate them and fail to restore functionality. To recapitulate the cellular complexity of the early fracture callus, we engineered human endothelialized callus organoids (hECOs) by co-culturing periosteum-derived skeletal progenitors with endothelial cells. This co-culture resulted in cellular self-assembly, leading to spatially organized, callus-like structures. Endothelial cells promoted skeletal progenitor cell expansion, extracellular matrix maturation, and progression toward hypertrophic cartilage, hallmarks of endochondral ossification. Multi-omics analyses identified endothelial cell-mediated activation of regenerative programs associated with skeletal maturation, matrix remodeling, and angiogenesis. Following brief in vitro differentiation, macroscale aggregates of hECOs supported rapid host vascularization and regeneration of critical-size tibial defects in immunocompromised mice. Donor-derived cells actively contributed to early regeneration but were progressively replaced during remodeling, consistent with hECOs functioning as transient biological templates that guide host-mediated bone regeneration.
中文摘要:大段骨缺损仍是重大临床挑战,因为当前治疗方法无法有效使其再生,也未能恢复功能。为再现早期骨折骨痂的细胞复杂性,我们通过将骨膜来源的骨骼祖细胞与内皮细胞共培养,构建了人内皮化骨痂类器官(hECOs)。这种共培养导致细胞自组装,形成空间有序、类似骨痂的结构。内皮细胞促进了骨骼祖细胞扩增、细胞外基质成熟以及向肥大软骨的进展,这些都是软骨内成骨的标志。多组学分析发现,内皮细胞介导了与骨骼成熟、基质重塑和血管生成相关的再生程序的激活。在短暂的体外分化后,hECOs 的宏观聚集体支持了免疫缺陷小鼠中临界尺寸胫骨缺损的快速宿主血管化和再生。供体来源细胞积极促进了早期再生,但在重塑过程中逐渐被替换,这与 hECOs 作为瞬时生物模板、引导宿主介导的骨再生相一致。
Postoperative cognitive dysfunction (POCD) is a common complication of surgery in elderly patients, and no pharmacological therapy has been approved. Although indoleamine 2,3-dioxygenase 1 (IDO1)-driven kynurenine pathway activation has been linked to perioperative neurocognitive impairment, neither the cellular source of this activation in the hippocampus nor its upstream transcriptional control has been defined. In a tibial fracture model in aged mice, anesthesia and surgery raised hippocampal pro-inflammatory cytokines and IDO1, the latter predominantly in microglia, increased the kynurenine-to-tryptophan ratio, and produced cognitive impairment, dendritic simplification and synaptic loss. IDO1 inhibition with 1-methyl-DL-tryptophan attenuated these deficits, whereas exogenous L-kynurenine reproduced the cognitive impairment in surgery-naive mice, indicating that IDO1-driven tryptophan catabolism contributes to postoperative cognitive injury. Berberine improved cognition dose-dependently and attenuated the dendritic, synaptic and metabolic changes; at the effective dose it reached the hippocampus at concentrations 2.6-fold those in plasma. Network pharmacology, molecular docking and molecular dynamics simulation identified STAT3 among candidate transcriptional regulators; surface plasmon resonance demonstrated direct binding, a cellular thermal shift assay confirmed engagement of endogenous STAT3 in microglia, and an Ido1 promoter-luciferase reporter showed that berberine suppressed STAT3-dependent transcription. Microglia-targeted Ido1 overexpression attenuated the protection conferred by berberine, indicating that microglial IDO1 mediates a substantial part of its action. These findings identify the microglial STAT3-IDO1 axis as a candidate target for perioperative neuroprotection and support further translational evaluation of berberine in this setting.
中文摘要:术后认知功能障碍(POCD)是老年患者手术后常见并发症,目前尚无获批的药物治疗。尽管吲哚胺2,3-双加氧酶1(IDO1)驱动的犬尿氨酸通路激活与围术期神经认知损害有关,但海马中该激活的细胞来源及其上游转录调控尚未明确。在老年小鼠胫骨骨折模型中,麻醉和手术升高海马促炎细胞因子和IDO1,后者主要位于小胶质细胞,增加犬尿氨酸与色氨酸比值,并导致认知损害、树突简化及突触丢失。用1-甲基-DL-色氨酸抑制IDO1可减轻这些缺陷,而外源性L-犬尿氨酸可在未手术小鼠中重现认知损害,表明IDO1驱动的色氨酸分解代谢参与术后认知损伤。小檗碱呈剂量依赖性改善认知,并减轻树突、突触和代谢改变;在有效剂量下,其到达海马的浓度是血浆浓度的2.6倍。网络药理学、分子对接和分子动力学模拟鉴定STAT3为候选转录调控因子之一;表面等离子体共振显示直接结合,细胞热位移实验证实小胶质细胞内源性STAT3的结合,Ido1启动子-荧光素酶报告基因显示小檗碱抑制STAT3依赖性转录。小胶质细胞靶向Ido1过表达减弱了小檗碱的保护作用,表明小胶质细胞IDO1介导其大部分作用。这些发现将小胶质细胞STAT3-IDO1轴确定为围术期神经保护的候选靶点,并支持在此背景下对小檗碱进行进一步转化评估。
5关节外科/置换 (3篇)
临床研究 (1篇)
Although systematic reviews, meta-analyses, and network meta-analyses are central to evidence-based medicine, most of those assessing the effectiveness of perioperative analgesic interventions have critical limitations that may lead to flawed conclusions, making them clinically uncertain: major concerns include the lack of rigorous inclusion and exclusion criteria, failure to critically assess the quality of the studies, heterogeneity of included studies, and poor quality of included studies (bias, use of basic analgesics, lack of dynamic pain scores, inadequate follow-up, fragility, spin, inaccurate interpretation, etc.). Importantly, clinical guidelines based on such meta-analyses may be inaccurate, despite the use of well-recognised sophisticated complex statistical analyses, which may not compensate for the inherent flaws or study heterogeneity. A properly conducted meta-analysis would have a meticulous systematic review with inclusion of homogenous RCTs, and the included studies would be assessed critically for current clinical relevance including well-defined early mobilisation, the use of basic analgesics, assessment of functional pain and recovery, and clinically relevant reductions in pain and opioid use. Overall, critical appraisal, careful interpretation, and judicious application of meta-analyses are necessary before using them in guidelines and day-to-day practice.
中文摘要:尽管系统评价、Meta分析和网状Meta分析是循证医学的核心,但大多数评估围手术期镇痛干预有效性的此类研究存在关键局限性,可能导致错误结论,使其在临床上具有不确定性:主要问题包括缺乏严格的纳入和排除标准、未能批判性评估研究质量、纳入研究间的异质性以及纳入研究质量较差(偏倚、使用基础镇痛药、缺乏动态疼痛评分、随访不足、脆弱性、夸大性表述、不准确解读等)。重要的是,基于此类Meta分析的临床指南可能不准确,尽管使用了公认的复杂精密统计分析方法,但这些方法可能无法弥补固有缺陷或研究异质性。一项正确实施的Meta分析应具有细致的系统评价,纳入同质性随机对照试验,并且应对纳入研究进行批判性评估,以判断其当前临床相关性,包括明确定义的早期活动、基础镇痛药的使用、功能疼痛和恢复评估,以及疼痛和阿片类药物使用方面具有临床意义的减少。总体而言,在将Meta分析用于指南和日常实践之前,必须进行批判性评价、谨慎解读和明智应用。
基础研究 (2篇)
The environmental degradation of polyethylene (PE) plastic is commonly described as a slow fragmentation process, generated by radical oxidation induced by sunlight, followed by gradual release of additives. Here, we challenge this view by applying a microwave-activated hydrogen peroxide (MW/H₂O₂) system able to reproduce key oxidative signatures observed during polyethylene weathering and allows study of particle release and additive release. We show that micro- and nanoplastics form concurrently, driven by early oxidative embrittlement and the development of surface cracks linked to structural heterogeneity. ATR-FTIR and depth-resolved O-PTIR spectroscopy reveal pronounced chemical transformations at the PE surface (including hydroxyl, and carbonyl groups formation) that trigger crystallinity changes, plastic swelling, and enhanced susceptibility to mechanical fracture. Using multimodal chemical analysis (µ-XRF, ICP-MS), we reveal selective migration of metallic additives (Ti, Cr, Fe, Ca), with surface enrichment directly correlated to the oxidation state of PE. Correlative analysis demonstrates that additive migration is promoted by surface oxidation and microstructural weakening, with Fick law modeling yielding diffusion coefficients up to 1.4 × 10⁻11 m² s⁻¹. These results provide mechanistic insight into how aged plastics act as dynamic vectors for particulate and chemical contaminants, highlighting the need to integrate additive release into environmental risk assessments.
中文摘要:聚乙烯(PE)塑料的环境降解通常被描述为一个缓慢的破碎过程,由阳光诱导的自由基氧化产生,随后是添加剂的逐渐释放。在此,我们通过应用微波激活过氧化氢(MW/H₂O₂)体系来挑战这一观点,该体系能够复现聚乙烯风化过程中观察到的关键氧化特征,并允许研究颗粒释放和添加剂释放。我们发现,微塑料和纳米塑料同时形成,由早期氧化脆化以及与结构不均匀性相关的表面裂纹发展所驱动。ATR-FTIR和深度分辨O-PTIR光谱揭示了PE表面显著的化学转变(包括羟基和羰基的形成),这些转变触发结晶度变化、塑料溶胀以及对机械断裂的敏感性增强。使用多模态化学分析(µ-XRF、ICP-MS),我们揭示了金属添加剂(Ti、Cr、Fe、Ca)的选择性迁移,其表面富集与PE的氧化状态直接相关。相关性分析表明,添加剂迁移受到表面氧化和微观结构弱化的促进,Fick定律建模得到的扩散系数高达1.4 × 10⁻11 m² s⁻¹。这些结果为老化塑料如何作为颗粒和化学污染物的动态载体提供了机制性见解,突出了将添加剂释放纳入环境风险评估的必要性。
Rheumatoid arthritis (RA) is a chronic autoimmune disease marked by synovial inflammation and progressive joint destruction, driven in part by the aggressive behaviour of synovial fibroblasts (SFs). Emerging evidence suggests that metabolic dysfunction in SFs contributes to RA pathogenesis. Studying autoantibody-positive at-risk individuals who have not yet developed clinical arthritis (RA-risk) offers a unique opportunity to investigate early disease mechanisms. Our previous work identified a transcriptional downregulation of genes involved in lipid and fatty acid metabolism in synovium samples of RA-risk individuals who later developed RA, even in the absence of overt immune cell infiltration. Here, we hypothesised that these alterations reflect an early metabolic shift in SFs. To investigate this, we compared transcriptomic profiles and lipid metabolism in SFs from RA-risk individuals, patients with RA and osteoarthritis (OA), and age-matched noninflammatory orthopaedic injury controls. RA and RA-risk SFs displayed distinct transcriptional signatures compared with controls, including dysregulation of lipid metabolism. Despite retained adipogenic differentiation potential, RA, RA-risk, and OA SFs showed reduced baseline lipid droplet (LD) content compared with controls. In RA and RA-risk SFs, this reduction was a result of enhanced LD lipolysis, plausibly as a result of decreased G0S2 expression, and could be reversed by adipose triglyceride lipase inhibition. Furthermore, stimulating G0S2 expression coincided with a reduced myeloid-supporting SF phenotype. Overall, these findings suggest that early lipid metabolic alterations in SFs represent important shifts in cellular function that precedes clinical disease and highlight the need to further interrogate the role of lipid metabolism in RA progression.
中文摘要:类风湿关节炎(RA)是一种慢性自身免疫性疾病,其特征为滑膜炎症和进行性关节破坏,部分由滑膜成纤维细胞(SFs)的侵袭性行为驱动。新出现的证据表明,SFs中的代谢功能障碍参与RA发病机制。研究尚未发生临床关节炎的自身抗体阳性高危个体(RA-risk)为了解早期疾病机制提供了独特机会。我们既往工作发现,在后来发展为RA的RA-risk个体滑膜样本中,参与脂质和脂肪酸代谢的基因转录下调,即使没有明显免疫细胞浸润。在此,我们假设这些改变反映了SFs中早期代谢转变。为研究这一点,我们比较了来自RA-risk个体、RA和骨关节炎(OA)患者以及年龄匹配的非炎症性骨科损伤对照的SFs的转录组谱和脂质代谢。RA和RA-risk SFs与对照相比显示出不同的转录特征,包括脂质代谢失调。尽管保留成脂分化潜能,RA、RA-risk和OA SFs的基线脂滴(LD)含量较对照减少。在RA和RA-risk SFs中,这种减少是LD脂解增强的结果,可能由G0S2表达降低所致,并且可通过抑制脂肪甘油三酯脂肪酶逆转。此外,刺激G0S2表达与髓系支持性SF表型减弱同时出现。总体而言,这些发现提示SFs中早期脂质代谢改变代表先于临床疾病的细胞功能重要转变,并强调需要进一步探究脂质代谢在RA进展中的作用。
6脊柱外科 (2篇)
临床研究 (1篇)
Early scoliosis screening enables timely intervention and may prevent disease progression. However, gait-based screening remains challenging: abnormalities are often subtle, labeled data are limited, and multimodal analysis must handle cross-modal discrepancy and missing modalities. To address these challenges, we propose Uncertainty-Aware Multimodal Gait Representation Learning (UMGRL), a cross-modal gait representation learning framework that transfers knowledge from large-scale gait data to scoliosis screening. To learn transferable representations robust to missing modalities, we develop a teacher-student paradigm. A shared latent projector and disentanglement module decompose multimodal features into modality-invariant geometry and modality-specific attributes, enabling cross-modal alignment while preserving complementary information. Modality dropout and representation prediction further allow the student to recover task-ready representations of missing modalities from available inputs. For downstream screening, we employ Dynamic Time Warping (DTW) to partition videos into phase-consistent bags for temporal alignment, followed by Perceiver IO-based fusion to capture long-range dependencies across modalities and gait cycles. To enhance sensitivity to borderline cases near the 10° Cobb threshold, we introduce a borderline-focused branch. Finally, we incorporate Evidential Deep Learning (EDL) for uncertainty-aware prediction and reliable triage. Experiments on Scoliosis1K demonstrate superior performance, particularly under incomplete-modality settings and on clinically ambiguous cases. These results suggest that UMGRL provides a promising path toward scalable, radiation-free scoliosis screening.
中文摘要:早期脊柱侧弯筛查有助于及时干预,并可能预防疾病进展。然而,基于步态的筛查仍面临挑战:异常往往较细微,标注数据有限,多模态分析还需处理跨模态差异和模态缺失。为应对这些挑战,我们提出不确定性感知多模态步态表征学习(UMGRL),这是一种跨模态步态表征学习框架,可将大规模步态数据中的知识迁移至脊柱侧弯筛查。为学习对模态缺失具有鲁棒性的可迁移表征,我们开发了一种教师-学生范式。共享潜在投影器和解耦模块将多模态特征分解为模态不变的几何特征和模态特有的属性,从而在保持互补信息的同时实现跨模态对齐。模态丢弃和表征预测进一步使学生能够从可用输入中恢复缺失模态的任务就绪表征。对于下游筛查,我们采用动态时间规整(DTW)将视频划分为相位一致的包以进行时间对齐,随后使用基于 Perceiver IO 的融合来捕获跨模态和步态周期的长程依赖。为提高对接近 10° Cobb 角阈值的边缘病例的敏感性,我们引入了一个以边缘病例为重点的分支。最后,我们引入证据深度学习(EDL)以实现不确定性感知预测和可靠分诊。在 Scoliosis1K 上的实验表明其性能优越,尤其是在模态不完整设置和临床模糊病例中。这些结果表明,UMGRL 为可扩展、无辐射的脊柱侧弯筛查提供了一条有前景的路径。
基础研究 (1篇)
Spinal aging is a progressive degenerative process involving structural and functional decline of the spine as a whole and of its individual components, ultimately contributing to the development of degenerative spinal diseases (DSDs). Previous studies have largely focused on local spinal tissues or the intervertebral disc (IVD). However, recent advances in geroscience indicate that spinal degeneration is not an isolated local event, but is influenced by systemic aging through a multi-organ aging network. Accordingly, this review proposes a "from local to systemic" framework to better understand the mechanisms underlying spinal aging. At the local level, spinal aging follows heterogeneous trajectories, with intervertebral disc degeneration (IVDD) often serving as a central process. Different DSDs share common pathological mechanisms, and their anatomical proximity allows them to interact biomechanically. Therefore, the spine should be regarded as an integrated organ system within systemic aging. Based on this concept, we propose that vertebral osteoporosis and paraspinal muscle degeneration should also be incorporated into the framework of spinal aging and DSDs. At the systemic level, immunosenescence, skeletal muscle aging, neural and vascular aging, digestive system aging, endocrine system aging, and nutrient-sensing dysregulation may collectively affect the spine through circulating inflammatory factors, senescence-associated secretory phenotypes, metabolic mediators, endocrine signals, and mechanical loading, thereby influencing the susceptibility, progression, clinical phenotypes, and treatment responses of DSDs. We further discuss clinical translation in spinal aging, including anatomical barriers to drug delivery and emerging strategies to overcome them, and summarize therapeutic approaches based on multi-organ aging. Ultimately, this review emphasizes that future DSDs treatment should achieve more precise stratification, move beyond lesion-centered local interventions, and incorporate systemic anti-aging strategies to optimize long-term clinical outcomes in patients with DSDs.
中文摘要:脊柱衰老是一个进行性退变过程,涉及整个脊柱及其各个组成部分的结构与功能衰退,最终促进退变性脊柱疾病(DSDs)的发生。既往研究大多聚焦于脊柱局部组织或椎间盘(IVD)。然而,老年科学的最新进展表明,脊柱退变并非孤立的局部事件,而是通过多器官衰老网络受到全身性衰老的影响。因此,本综述提出「从局部到全身」的框架,以更好地理解脊柱衰老的机制。在局部层面,脊柱衰老遵循异质性轨迹,其中椎间盘退变(IVDD)常作为核心过程。不同DSDs具有共同的病理机制,且其解剖位置邻近使它们能够在生物力学上相互作用。因此,应将脊柱视为全身性衰老中的一个整合器官系统。基于这一概念,我们提出椎体骨质疏松和椎旁肌肉退变也应纳入脊柱衰老和DSDs的框架。在全身层面,免疫衰老、骨骼肌衰老、神经和血管衰老、消化系统衰老、内分泌系统衰老以及营养感知失调,可能通过循环炎症因子、衰老相关分泌表型、代谢介质、内分泌信号和机械负荷共同影响脊柱,从而影响DSDs的易感性、进展、临床表型和治疗反应。我们进一步讨论脊柱衰老的临床转化,包括药物递送的解剖学屏障及克服这些屏障的新兴策略,并总结基于多器官衰老的治疗方法。最终,本综述强调,未来DSDs治疗应实现更精准的分层,超越以病变为中心的局部干预,并纳入全身抗衰老策略,以优化DSDs患者的长期临床结局。
7运动医学/关节镜 (2篇)
基础研究 (2篇)
Meniscus repair is often limited by poor intrinsic healing, an adverse oxidative-inflammatory microenvironment, and insufficient mechanical continuity across the tear interface. Here, we engineered a solvent-free injectable polyurethane adhesive (PUA) loaded with connective tissue growth factor (PUA@CTGF) for meniscus tear repair that combines rapid wet interfacial stabilization, compliant defect filling, and prolonged CTGF release. The adhesive showed rapid in situ curing, high apparent initial wet lap-shear strength, and stable short-cycle compressive behavior in a 100-cycle loading-unloading test. In vitro, PUA@CTGF reduced oxidative stress-associated mitochondrial injury, modulated macrophage-associated inflammatory markers toward a more repair-supportive profile, promoted meniscal cell migration, and enhanced fibrochondrogenic matrix synthesis when combined with cyclic tensile stimulation. In a rabbit outer-vascular-zone meniscus tear model, PUA@CTGF improved repair-region continuity, matrix deposition, and tensile properties and attenuated early joint degenerative changes relative to untreated, suture, fibrin, and PUA controls, although native meniscal tensile properties were not fully restored during the 12-week observation period. Transcriptomic profiling identified mechanotransduction-related signatures, while inhibitor-supported in vitro analyses showed that GsMTx4 attenuated dynamic-loading-induced Ca2+ and YAP responses, supporting a GsMTx4-sensitive mechanotransduction response. These findings support PUA@CTGF as a bioactive polyurethane adhesive platform for wet, mechanically active meniscal repair interfaces. STATEMENT OF SIGNIFICANCE: Meniscus tears are difficult to heal because the injured interface is wet, mechanically active, and biologically hostile. This study introduces a solvent-free injectable polyurethane adhesive that rapidly stabilizes wet meniscal tears while providing localized delivery of connective tissue growth factor. By combining catechol-assisted wet adhesion, compliant defect filling, short-cycle energy dissipation, reactive oxygen species buffering, and prolonged CTGF release, the adhesive provides interfacial stabilization and microenvironmental regulation. In vitro and rabbit studies showed enhanced cell migration and matrix-associated responses, improved repair-region continuity and tensile properties, and attenuation of early joint degenerative changes. This work advances biomaterial design by integrating wet interfacial stabilization with localized biochemical delivery for the repair of mechanically active, load-bearing soft-tissue interfaces.
中文摘要:半月板修复常受限于内在愈合能力差、不利的氧化炎症微环境以及撕裂界面机械连续性不足。在此,我们设计了一种无溶剂可注射聚氨酯黏合剂(PUA),其负载结缔组织生长因子(PUA@CTGF),用于半月板撕裂修复,兼具快速湿态界面稳定、顺应性缺损填充和CTGF持续释放。该黏合剂在100次加载-卸载试验中表现出快速原位固化、较高的表观初始湿态搭接剪切强度和稳定的短周期压缩行为。体外实验中,PUA@CTGF可减轻氧化应激相关线粒体损伤,将巨噬细胞相关炎症标志物调节至更支持修复的表型,促进半月板细胞迁移,并在联合循环拉伸刺激时增强纤维软骨基质合成。在兔外侧血管区半月板撕裂模型中,与未处理、缝线、纤维蛋白和PUA对照相比,PUA@CTGF改善了修复区连续性、基质沉积和拉伸性能,并减轻了早期关节退变,尽管在12周观察期内天然半月板拉伸性能未完全恢复。转录组分析识别出机械转导相关特征,而抑制剂支持的体外分析显示GsMTx4可减弱动态加载诱导的Ca2+和YAP反应,支持存在GsMTx4敏感的机械转导反应。这些发现支持PUA@CTGF作为一种生物活性聚氨酯黏合剂平台,用于湿态、机械活跃的半月板修复界面。意义声明:半月板撕裂难以愈合,因为损伤界面湿润、机械活跃且生物学环境不利。本研究引入一种无溶剂可注射聚氨酯黏合剂,可快速稳定湿态半月板撕裂,同时局部递送结缔组织生长因子。通过结合儿茶酚辅助的湿态黏附、顺应性缺损填充、短周期能量耗散、活性氧缓冲和CTGF持续释放,该黏合剂可提供界面稳定和微环境调控。体外和兔研究显示细胞迁移和基质相关反应增强,修复区连续性和拉伸性能改善,早期关节退变减轻。这项工作通过将湿态界面稳定与局部生化递送相结合,推动了生物材料设计,用于修复机械活跃、承重的软组织界面。
Over 400,000 anterior cruciate ligament (ACL) reconstructions are performed worldwide annually. The ability of patients to return to their pre-injury or adapted level remains limited. Although autografts and allografts are recognized as good choices for ACL reconstruction, postoperative complications are frequently reported. The emergence of artificial ligaments offers a promising strategy to solve these challenging medical conditions. However, artificial grafts composed of different materials have been associated with complications such as chronic effusions, synovitis, and graft failure to varying degrees. Although great progress has been made in modifying artificial grafts, the optimal strategy remains to be explored. Magnesium and recombinant spidroin have been proven to be promising implantable materials that can facilitate osteogenesis both in vitro and in vivo, thus exhibiting good potential for orthopaedic implants or grafts. In this study, a novel nano-to-macroscale dual core-shell structured bioartificial ligament integrating magnesium and recombinant spidroin has been developed using conjugate coaxial electrospinning. This innovative graft promoted graft-bone integration by facilitating early expression of osteogenic, neurogenic, and cell adhesion markers (e.g., BMP2, RUNX2, CGRP, and ITGA5) at the interface and accelerating new bone mineralization around the bone tunnel. These effects resulted in improved healing outcomes after ACL reconstruction in a rat model, suggesting significant clinical potential for future ACL applications.
中文摘要:全球每年实施超过40万例前交叉韧带(ACL)重建术。患者恢复到受伤前或适应后水平的能力仍然有限。尽管自体移植物和同种异体移植物被认为是ACL重建的良好选择,但术后并发症常有报道。人工韧带的出现为解决这些具有挑战性的医学问题提供了一种有前景的策略。然而,由不同材料组成的人工移植物可在不同程度上伴发慢性积液、滑膜炎和移植物失败等并发症。尽管在改良人工移植物方面已取得很大进展,但最佳策略仍有待探索。镁和重组蛛丝蛋白已被证明是有前景的可植入材料,能够在体外和体内促进成骨,因此作为骨科植入物或移植物具有良好的潜力。在本研究中,通过共轭同轴静电纺丝开发了一种整合镁和重组蛛丝蛋白的新型纳米至宏观尺度双核壳结构生物人工韧带。这种创新移植物通过促进界面处成骨、神经源性和细胞黏附标志物(如BMP2、RUNX2、CGRP和ITGA5)的早期表达,并加速骨隧道周围的新骨矿化,从而促进移植物-骨整合。这些效应使大鼠模型中ACL重建后的愈合结果得到改善,提示其未来在ACL应用方面具有显著的临床潜力。
8感染/骨髓炎 (1篇)
基础研究 (1篇)
Osteomyelitis (OM) is a severe inflammatory bone disease caused by pathogen invasion, representing a major challenge in orthopedic surgery. Staphylococcus aureus (S. aureus) is the predominant causative pathogen across all OM subtypes, and its increasing antibiotic resistance has further complicated clinical management. Despite advances in antibiotic therapy and surgical debridement, treatment failure and disease recurrence remain unacceptably high. Emerging evidence suggests that these poor outcomes are largely attributed to the intricate host-pathogen interplay within the bone microenvironment, yet the underlying immunological mechanisms remain incompletely understood. This review provides a comprehensive overview of the epidemiological characteristics, classification, clinical features, pathophysiology, and current diagnostic and therapeutic strategies for OM, with a particular focus on host immune dysregulation in disease initiation and chronicity, elucidating the mechanisms underlying immunosuppressive niche formation and persistent bone destruction. We further dissect the multifaceted immune evasion strategies employed by S. aureus, including biofilm formation, intracellular persistence, and abscess barrier construction, which collectively drive infection chronicity and progressive bone destruction. By synthesizing recent advances in osteoimmunology, this review identifies critical knowledge gaps and proposes potential targeted immunomodulatory interventions, offering promising avenues to overcome conventional treatment limitations.
中文摘要:骨髓炎(OM)是一种由病原体入侵引起的严重炎症性骨病,是骨科手术中的一大挑战。金黄色葡萄球菌(S. aureus)是所有OM亚型中最主要的致病菌,其日益增加的抗生素耐药性使临床管理进一步复杂化。尽管抗生素治疗和手术清创取得了进展,但治疗失败和疾病复发率仍然高得难以接受。新出现的证据表明,这些不良结局在很大程度上归因于骨微环境中宿主与病原体之间复杂的相互作用,但其潜在的免疫学机制仍未完全阐明。本综述全面概述了OM的流行病学特征、分类、临床特征、病理生理学以及当前的诊断和治疗策略,特别关注疾病发生和慢性化过程中的宿主免疫失调,阐明免疫抑制微环境形成和持续性骨破坏的机制。我们进一步剖析了金黄色葡萄球菌采用的多方面免疫逃逸策略,包括生物膜形成、胞内持续存在和脓肿屏障构建,这些策略共同驱动感染慢性化和进行性骨破坏。通过综合骨免疫学的最新进展,本综述确定了关键的知识空白,并提出了潜在的靶向免疫调节干预措施,为克服传统治疗局限性提供了有前景的途径。
9肌骨疾病 (1篇)
基础研究 (1篇)
Musculoskeletal disorders (MSDs), including osteoporosis (OP), osteoarthritis (OA), and rheumatoid arthritis (RA), represent a stubborn burden in modern medicine. They share a breakdown in mitochondrial homeostasis. Mitochondrial dysfunction serves as a central pathogenic mechanism unifying these conditions and driving a paradigm shift from symptomatic management to mechanism-based therapeutic strategies. In this review, we examine how mitochondrial defects affect key cell types in bone, cartilage, and muscle, including osteoblasts, osteocytes, osteoclasts, chondrocytes, and skeletal muscle cells, with a focus on osteoporosis (OP), osteoarthritis (OA), and rheumatoid arthritis (RA) as the three primary musculoskeletal conditions that share mitochondrial dysfunction as a unifying mechanism. Impaired energy production, altered dynamics, defective quality control, and redox imbalance each contribute to disease progression. These disturbances drive oxidative damage, metabolic reprogramming, impaired mitophagy, and the release of pro-inflammatory signals known as mtDAMPs. Importantly, such defects are not irreversible, we further synthesize the emerging landscape of mitochondria-targeted strategies. These include antioxidants like MitoQ and SkQ1, metabolic modulators such as metformin and NAD⁺ boosters, mitophagy inducers like urolithin A, fission inhibitors including Mdivi-1, senolytic agents, and even mitochondrial transplantation. We conclude by proposing a precision medicine framework that matches specific mitochondrial abnormalities with mechanism-based interventions. Drawing on recent preclinical and clinical evidence, this review positions mitochondrial crosstalk as a promising foundation for developing disease-modifying therapies in musculoskeletal medicine.
中文摘要:肌骨疾病(MSDs),包括骨质疏松症(OP)、骨关节炎(OA)和类风湿关节炎(RA),是现代医学中一个顽固的负担。它们共同存在线粒体稳态的破坏。线粒体功能障碍作为核心致病机制,统一了这些病症,并推动从症状管理向基于机制的治疗策略的范式转变。在本综述中,我们探讨线粒体缺陷如何影响骨、软骨和肌肉中的关键细胞类型,包括成骨细胞、骨细胞、破骨细胞、软骨细胞和骨骼肌细胞,重点关注骨质疏松症(OP)、骨关节炎(OA)和类风湿关节炎(RA)这三种主要的肌骨疾病,它们共同以线粒体功能障碍为统一机制。能量产生受损、动力学改变、质量控制缺陷和氧化还原失衡各自促进疾病进展。这些紊乱驱动氧化损伤、代谢重编程、线粒体自噬受损以及被称为mtDAMPs的促炎信号的释放。重要的是,这些缺陷并非不可逆,我们进一步总结了线粒体靶向策略的新兴图景。这些策略包括抗氧化剂如MitoQ和SkQ1、代谢调节剂如二甲双胍和NAD⁺增强剂、线粒体自噬诱导剂如尿石素A、裂变抑制剂包括Mdivi-1、衰老细胞清除剂,甚至线粒体移植。最后,我们提出一个精准医学框架,将特定的线粒体异常与基于机制的干预措施相匹配。基于最近的临床前和临床证据,本综述将线粒体串扰定位为开发肌骨医学中疾病修饰疗法的有前景的基础。
10创伤骨科 (1篇)
临床研究 (1篇)
The "2026 Guidelines for Adult Stroke Rehabilitation and Recovery" replaces the 2016 "Guidelines for Adult Stroke Rehabilitation and Recovery." This updated guideline is intended to provide a comprehensive, up-to-date, evidence-based set of recommendations. The intended audience includes physicians, allied health professionals, and caregivers. A comprehensive search for literature published since the 2016 guideline, derived from research involving human participants, published in English, and indexed in MEDLINE, PubMed, Cochrane Library, and other selected databases relevant to this guideline, was conducted between June and October 2025. Other documents on related subject matter previously published by the American Heart Association were also reviewed. This guideline provides recommendations based on the most current evidence available for stroke rehabilitation and recovery. Key updates include new and revised recommendations across the stroke recovery continuum, including the assessment and treatment of medical comorbidities, fracture risk, fall prevention, technology-enabled rehabilitation, caregiver support, participation, and safe return to work and driving. Although this guideline reflects significant advances, it also highlights gaps in knowledge and underscores the urgent need for continued research to further refine and improve treatment strategies.
中文摘要:《2026年成人卒中康复与恢复指南》取代了2016年《成人卒中康复与恢复指南》。本更新指南旨在提供一套全面、最新、基于证据的建议。目标读者包括医生、相关健康专业人员和照护者。2025年6月至10月期间,针对自2016年指南以来发表的文献进行了全面检索,这些文献来源于涉及人类参与者的研究、以英文发表,并收录于MEDLINE、PubMed、Cochrane Library及与本指南相关的其他选定数据库中。同时,也审查了美国心脏协会先前发表的关于相关主题的其他文件。本指南基于当前可获得的关于卒中康复与恢复的最新证据提供建议。关键更新包括贯穿卒中恢复连续体的新建议和修订建议,涉及医学合并症的评估与治疗、骨折风险、跌倒预防、技术辅助康复、照护者支持、参与以及安全重返工作和驾驶。尽管本指南反映了重大进展,但也指出了知识空白,并强调迫切需要继续研究,以进一步完善和改进治疗策略。
11肩肘外科 (1篇)
临床研究 (1篇)
Shoulder pain is a common and disabling condition most often managed in primary care. This review provides an evidence-based update on the diagnosis and management of shoulder pain to support clinical decision-making and improve patient outcomes. Shoulder pain arises from benign, self-limiting soft-tissue disorders or rare but serious causes. In primary care, most cases are nontraumatic and involve periarticular soft tissues. The subacromial region is the most frequent source of pain, and the term subacromial pain is preferred over overlapping and inconsistently defined labels such as rotator cuff tendinopathy or tear, impingement syndrome, or subacromial bursitis. Less commonly, pain originates from the glenohumeral joint, as in glenohumeral osteoarthritis or adhesive capsulitis. Assessment should focus on a detailed history and physical examination to assess pain patterns and movement limitation and to exclude serious causes, such as infection, malignant neoplasm, or nonshoulder referred pain. Once these are excluded, first-line treatment is similar for most patients and aligns with recommended care for other regional musculoskeletal concerns: education about the favorable natural history, symptom relief and activity modification if needed, and watchful waiting. Early imaging is not indicated in the absence of significant trauma or suspicious features, such as fever, unexplained weight loss, or history of malignant neoplasm, as structural abnormalities often do not correlate with symptoms, rarely alter management, and may lead to overdiagnosis and overtreatment. Specialist referral should be reserved for suspected serious pathology, such as infection, malignant neoplasm, fracture, or dislocation; significant functional or neurologic deficit; features suggestive of systemic inflammatory disease; or persistent or worsening pain and debility. High-certainty evidence indicates that subacromial pain does not benefit from surgical intervention. Shoulder pain is the third most common musculoskeletal presentation in primary care. Although causes vary, the initial management is largely the same once serious conditions have been excluded. Most patients with subacromial pain will fully recover with minimal intervention and can be safely treated with supportive care. Imaging and referral to surgical subspecialists should be reserved for rare and carefully selected cases to avoid unnecessary intervention.
中文摘要:肩痛是一种常见且可致残的病症,最常在基层医疗中处理。本综述提供关于肩痛诊断和管理的循证更新,以支持临床决策并改善患者结局。肩痛可源于良性、自限性软组织疾患,也可源于罕见但严重的原因。在基层医疗中,大多数病例为非创伤性,并涉及关节周围软组织。肩峰下区域是最常见的疼痛来源,因此更倾向于使用「肩峰下疼痛」这一术语,而非相互重叠且定义不一致的标签,如肩袖肌腱病或撕裂、撞击综合征或肩峰下滑囊炎。较少见情况下,疼痛起源于盂肱关节,如盂肱关节骨关节炎或粘连性肩关节囊炎。评估应侧重于详细病史和体格检查,以评估疼痛模式和活动受限,并排除严重原因,如感染、恶性肿瘤或非肩部来源的牵涉痛。一旦排除这些情况,大多数患者的一线治疗相似,并与其他区域肌肉骨骼问题的推荐治疗一致:就良好的自然病程进行教育、必要时缓解症状和调整活动,以及观察等待。在没有显著创伤或可疑特征(如发热、不明原因体重下降或恶性肿瘤病史)的情况下,不推荐早期影像学检查,因为结构异常往往与症状不相关,很少改变管理,并可能导致过度诊断和过度治疗。专科转诊应保留用于疑似严重病变,如感染、恶性肿瘤、骨折或脱位;显著的功能或神经功能缺损;提示全身炎症性疾病的特征;或持续或加重的疼痛和虚弱。高确定性证据表明,肩峰下疼痛并不能从手术干预中获益。肩痛是基层医疗中第三常见的肌肉骨骼就诊问题。尽管病因各异,但一旦排除严重情况,初始管理基本相同。大多数肩峰下疼痛患者通过最小干预即可完全恢复,并可安全地接受支持治疗。影像学检查和转诊至外科亚专科应保留用于罕见且经过仔细选择的病例,以避免不必要的干预。
12假体周围感染 (1篇)
临床研究 (1篇)
Periprosthetic Joint Infection (PJI) represents one of the most serious complications following joint arthroplasty, with impactful consequences in the clinic and economy. Characterized by biofilm formation on implant surfaces, PJI poses significant therapeutic challenges due to the limited efficacy of systemic antibiotics and the increasing prevalence of multidrug-resistant bacteria. This review paper presents a comprehensive analysis of current and emerging antibacterial strategies designed to mitigate the risk of infection in total joint arthroplasty (TJA). It spans two decades of literature, from 2003 to 2025, with a particular focus on local antibiotic delivery systems, including bone cements, spacers, beads, and novel biomaterial carriers evaluated across in vitro assays, in vivo animal models, and in vivo clinical trials. A systematic search of the Web of Science Core Collection (1 January 2003-31 December 2025; last search: October 2025) identified 300 records; after de-duplication and screening, 138 studies met inclusion criteria (14 in vitro, 25 animal, 99 clinical). Evidence was synthesized using a clinical-pathway framework comparing PMMA-based strategies with resorbable depots, hydrogels, coatings/nanomaterials, and emerging antibiofilm agents. The performance of PolyMethylMethAcrylate (PMMA)-based Antibiotic-Loaded Bone Cements (ALBCs) is critically assessed, highlighting key limitations such as inconsistent drug release, suboptimal biofilm penetration, and their inability to degrade within the living tissue environment and consequently to not promote osseointegration. In contrast, recent developments in multifunctional scaffolds, bioresorbable polymers, and nanocomposite materials are explored as promising solutions for controlled antibiotic release, improved biocompatibility, and enhanced osseointegration. In addition to analysing drug release kinetics and antibacterial efficacy, this review discusses cytotoxicity, nephrotoxicity, and the systemic impact of locally delivered antibiotics. Particular attention is paid to the balance between therapeutic effectiveness and host safety. Furthermore, strategies against biofilm formation, such as surface modification, antimicrobial peptides, and metal-based coatings, are examined. By organizing the findings into a structured comparative framework, this review provides valuable insight into the advantages, limitations, and translational potential of each approach. Finally, future perspectives are outlined, emphasizing the need for advanced clinical validation of next-generation biomaterials that can simultaneously address infection control and regenerative requirements in orthopaedic surgery.
中文摘要:假体周围感染(PJI)是关节置换术后最严重的并发症之一,在临床和经济方面均造成重大影响。PJI以植入物表面形成生物膜为特征,由于全身抗生素疗效有限以及多重耐药菌日益流行,其治疗面临重大挑战。本综述对当前和新兴的抗菌策略进行了全面分析,这些策略旨在降低全关节置换术(TJA)的感染风险。综述涵盖2003年至2025年二十年文献,特别关注局部抗生素递送系统,包括骨水泥、间隔器、珠粒以及新型生物材料载体,这些系统在体外试验、体内动物模型和体内临床试验中进行了评估。对Web of Science核心合集(2003年1月1日至2025年12月31日;最后检索:2025年10月)进行系统检索,识别出300条记录;经去重和筛选后,138项研究符合纳入标准(14项体外研究、25项动物研究、99项临床研究)。证据采用临床路径框架进行综合,比较基于PMMA的策略与可吸收储库、水凝胶、涂层/纳米材料及新兴抗生物膜剂。对聚甲基丙烯酸甲酯(PMMA)基抗生素负载骨水泥(ALBCs)的性能进行批判性评估,强调其关键局限性,如药物释放不一致、生物膜穿透欠佳,以及无法在活体组织环境中降解并因此不能促进骨整合。相比之下,近期多功能支架、生物可吸收聚合物和纳米复合材料的发展被视为有前景的解决方案,可实现抗生素控制释放、改善生物相容性并增强骨整合。除分析药物释放动力学和抗菌效能外,本综述还讨论局部递送抗生素的细胞毒性、肾毒性及全身影响。特别关注治疗效果与宿主安全之间的平衡。此外,还审视了针对生物膜形成的策略,如表面改性、抗菌肽和金属基涂层。通过将研究结果组织为结构化的比较框架,本综述为每种方法的优势、局限性和转化潜力提供了有价值的见解。最后,概述了未来展望,强调需要对下一代生物材料进行高级临床验证,以同时满足骨科手术中的感染控制和再生需求。
13其他 (2篇)
临床研究 (2篇)
Virtual care is increasingly used for preoperative assessment. We aimed to estimate the noninferiority of virtual vs in-person anaesthesiology consultations with respect to 90-day morbidity and mortality in at-risk adults having noncardiac surgery. We conducted a retrospective observational comparative effectiveness study using a target trial emulation framework. Eligible participants were aged ≥40 yr, with an ASA physical status ≥3, having elective, noncardiac, non-orthopaedic, moderate- to high-risk surgery, and attended a preoperative anaesthesiology consultation in Ontario, Canada, between October 2020 and March 2022. Exposures were receipt of virtual vs in-person preoperative anaesthesiology consultation in the 60 days preceding surgery. The primary outcome was 90-day major morbidity or mortality (noninferiority margin of upper 95% confidence interval [CI] <1.10 on relative scale). Secondary outcomes included 90-day mortality, length of hospital stay, costs of care, and days alive and at home within 90 days (DAH90). Travel-attributable carbon emissions were also estimated. Analyses used instrumental variable and propensity score methods. Among 17 027 patients, 8399 (49.3%) received a virtual consultation. The primary outcome occurred in 2212 (26.3%) virtual consult patients and 2147 (24.9%) of 8628 in-person consult patients. Primary outcome noninferiority was inconclusive based on both instrumental variable (adjusted odds ratio [adj-OR] 1.02, 95% CI 0.92-1.13) and propensity-score adjusted (adj-OR 0.99, 95% CI 0.89-1.101) analyses. Noninferiority was observed for length of hospital stay, costs of care, and DAH90. In-person care was associated with an estimated increase of 8618 (SD 17 200) g CO2 per visit. Before moderate-to-high-risk noncardiac, non-orthopaedic elective surgery, the noninferiority of virtual vs in-person anaesthesiology consultation for major morbidity or mortality was inconclusive. Virtual care was noninferior for several secondary outcomes and associated with reduced carbon emissions. Further research is required to refine triage models and increase certainty regarding morbidity.
中文摘要:虚拟医疗越来越多用于术前评估。我们旨在评估在接受非心脏手术的高风险成人中,虚拟与面对面麻醉科会诊在90天并发症和死亡率方面的非劣效性。我们采用目标试验模拟框架开展了一项回顾性观察性比较效果研究。符合条件的研究对象为年龄≥40岁、ASA体格状态≥3级、接受择期非心脏非骨科中高风险手术,并于2020年10月至2022年3月期间在加拿大安大略省接受术前麻醉科会诊的患者。暴露为术前60天内接受虚拟或面对面术前麻醉科会诊。主要结局为90天大并发症或死亡(非劣效界值为相对尺度上95%置信区间[CI]上限<1.10)。次要结局包括90天死亡率、住院时长、医疗费用以及90天内存活且在家天数(DAH90)。还估算了与出行相关的碳排放。分析采用工具变量和倾向评分方法。在17 027例患者中,8399例(49.3%)接受了虚拟会诊。主要结局在2212例(26.3%)虚拟会诊患者和8628例面对面会诊患者中的2147例(24.9%)发生。基于工具变量(校正比值比[adj-OR] 1.02,95% CI 0.92-1.13)和倾向评分校正(adj-OR 0.99,95% CI 0.89-1.101)分析,主要结局的非劣效性结论尚不确定。住院时长、医疗费用和DAH90观察到非劣效性。面对面医疗与每次就诊估计增加8618(SD 17 200)g CO2相关。在中高风险非心脏、非骨科择期手术前,虚拟与面对面麻醉科会诊在主要并发症或死亡方面的非劣效性结论尚不确定。虚拟医疗在若干次要结局上非劣效,并与碳排放减少相关。需要进一步研究以完善分诊模型并提高对并发症结论的确定性。
Orforglipron (Foundayo™) is an orally administered, non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist being developed by Eli Lilly and Co. for use in long-term weight management and for the treatment of type 2 diabetes (T2D) among other indications. In April 2026, orforglipron received its first approval, in the USA, for use in combination with a reduced-calorie diet and increased physical activity for long-term weight management in adults with obesity or adults with overweight in the presence of one or more weight-related comorbid condition. Orforglipron has also been submitted for regulatory review in the EU for long-term weight management and T2D, in Japan for long-term weight management, and in Canada for T2D. In addition to long-term weight management and T2D treatment, orforglipron is currently under phase III clinical evaluation for use in the treatment of obstructive sleep apnoea, hypertension, stress urinary incontinence in females, osteoarthritis pain and peripheral arterial disease. This article summarises the milestones in the development of orforglipron leading to this first approval for long-term weight management in adults with obesity or overweight.
中文摘要:Orforglipron(Foundayo™)是一种口服给药的非肽类胰高血糖素样肽-1(GLP-1)受体激动剂,由礼来公司开发,用于长期体重管理以及2型糖尿病(T2D)等多种适应症。2026年4月,orforglipron在美国获得首次批准,用于联合减少热量饮食和增加体力活动,对肥胖成人或伴有至少一种体重相关合并症的超重成人进行长期体重管理。Orforglipron还已在欧盟提交长期体重管理和T2D的监管审评,在日本提交长期体重管理,在加拿大提交T2D。除长期体重管理和T2D治疗外,orforglipron目前正处于III期临床评价中,用于治疗阻塞性睡眠呼吸暂停、高血压、女性压力性尿失禁、骨关节炎疼痛和外周动脉疾病。本文总结了orforglipron开发过程中的里程碑,这些里程碑促成了其首次获批用于肥胖或超重成人的长期体重管理。